MIME-Version: 1.0 Content-Type: multipart/related; boundary="----=_NextPart_01C7C7C5.FDCE02D0" Dette dokument er en webside i én fil. Det kaldes også en webarkivfil. Hvis du kan se denne meddelelse, skyldes det, at webbrowseren eller editoren ikke understøtter webarkivfiler. Hent en webbrowser, der understøtter webarkivfiler, f.eks. Microsoft Internet Explorer. ------=_NextPart_01C7C7C5.FDCE02D0 Content-Location: file:///C:/E919C637/ArticlesofAssociationforIHTSDOv206302007.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"

Articles of Association
(vedtægter)
for
International Health Terminology Standa=
rds
Development Organisation
9
March 2007
(As
amended June 30 2007)
Version
2
(IHTSDO)
Table of Cont=
ents
1. Name, Place of Business and Governing Law
2.=
Purpose, Objects and Principles of the Associat=
ion
6.=
Affiliates and Sponsored Territories
10. Dissolution of the Association
16. Official Business Language
17. Definitions and Interpretation
18. Schedule 1 – MEMBER CONTACT Information=
span>
19. Schedule 2 – FEE ALLOCATION PROVISIONS
20. SCHEDULE 3 - SNOMED CT INTELLECTUAL PROPERTY
“SNOMED
SDO” (International Health Terminology Standards Development
Organisation (forening med
begrænset ansvar));
“SNOMED
Standards Development Organisation” (International Health Termino=
logy
Standards Development Organisation (forening
med begrænset ansvar));
“SSDO”
(International Health Terminology Standards Development Organisation (forening med begrænset ansvar)).
(a)&=
nbsp; &nbs=
p;
acquire,
own and administer the rights to
(b)&=
nbsp; &nbs=
p;
develop,
maintain, promote and enable the uptake and correct use of its Terminology
Products in health systems, services and products around the world; and
(c)&=
nbsp; &nbs=
p;
undertake
any or all activities incidental and conducive to achieving the Purpose of =
the
Association
for the benefit of the Members.
(a) = distribute any of its surpluses or= assets to its Members, except in accordance with Schedule 2 of these Articles; or<= o:p>
(b) =
retain accumulated surpluses that,=
in the
view of the Management Board, are not necessary or appropriate for the oper=
ation
and/or development of the Association and its activities.
(a) =
applied to the lowering of the Ann=
ual Fee,
in such a manner as is determined by the General Assembly in its Ordinary
Meeting; or
(b) =
if proposed by the Management Board and approved by
the General Assembly by a Super Majority, devote or contribute such surplus, or any portion there=
of, to
one or more projects or non-p=
rofit
organizations pursuing objectives consistent with the Objects of the
Association set forth in clauses 2.2.1 (a) - (b).
(a)&=
nbsp; &nbs=
p;
enhance
the health of humankind by facilitating better health information managemen=
t;
(b)&=
nbsp; &nbs=
p;
contribute
to improved delivery of care by clinical and social care professions;
(c)&=
nbsp; &nbs=
p;
facilitate
the accurate sharing of clinical and related health information, and the
semantic interoperability of health records;
(d)&=
nbsp; &nbs=
p;
encourage
global collaboration and cooperation with respect to the ongoing improvemen=
t of
the Terminology Products; and
(e)&=
nbsp; &nbs=
p;
provide
the foregoing on a globally co-ordinated basis, thereby enabling the Members
and the related organisations within their Territories to pool resources and
share benefits relating to the development and maintenance of, and their ut=
ilisation
of and reliance upon, the Terminology Products.
(a)&=
nbsp; &nbs=
p;
Charter
Members, and
(b)&=
nbsp; &nbs=
p;
Ordinary
Members.
(a)&=
nbsp; &nbs=
p;
The
National E-Health Transition Authority Ltd (ABN: 18 114 638 336) (NEHTA), a
public company limited by guarantee, as the Charter Member for
(b)&=
nbsp; &nbs=
p;
Canada
Health Infoway Inc., as the Charter Member for
(c)&=
nbsp; &nbs=
p;
The
Danish National Board of Health as the Charter Member for
(d)&=
nbsp; &nbs=
p;
The
Lithuanian Ministry of Health as the Charter Member for
(e)&=
nbsp; &nbs=
p;
Subject
to the condition subsequent set forth in clause 4.2.3, the State of the
(f)&=
nbsp; &nbs=
p;
The New
Zealand Ministry of Health, as the Charter Member for
(g)&=
nbsp; &nbs=
p;
The Government of the Kingdom of Sweden, represe=
nted
by the Ministry of Health and Social Affairs, as the Charter Member for =
span>Sweden;
(h)&=
nbsp; &nbs=
p;
The
Secretary of State for Health, acting through its agency NHS Connecting for
Health, as the Charter Member for =
The
United Kingdom of Great Britain, Northern Ireland, the Channel Islands and =
the
Isle of Man; and
(i)&=
nbsp; &nbs=
p;
The U.S.
National Library of Medicine (a unit of the National Institutes of Health,
Department of Health and Human Services) (NLM), a U.S.
(a)&=
nbsp; &nbs=
p;
either:
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
i. &nb=
sp;
an
agency of the national government of that Territory acting within its
authority; or
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
ii. &n=
bsp;
a
corporation or other duly constituted body (including a regional government=
or
statutory corporation); and
(b)&=
nbsp; &nbs=
p;
appropriately
endorsed by the national government of that Territory, or an appropriate ag=
ency
or authority within such national government, as being:
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
i. &nb=
sp;
suitable
to be the Member for and in respect of that Territory; and
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
ii. &n=
bsp;
an
organisation whose responsibilities and authorities appropriately include
establishing, monitoring, promoting or regulating concept-based systems of
clinical terminology for or within that Territory.
(a)&=
nbsp; &nbs=
p;
apply
in writing to the Association using such form, and accompanied by such
information, as the Management Board may prescribe (and which may vary by
applicant):
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
i. &nb=
sp;
demonstrating
fulfilment of the eligibility criteria set out in clause 4.3.2 of these Articles, and
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
ii. &n=
bsp;
agreeing
to be bound by these Articles (including its appendices), any other policie=
s or
other requirements specifically referred to in these Articles, and the
Regulations;
(b)&=
nbsp; &nbs=
p;
be
accepted as a Member of the Association by decision of the Management Board
(which decision shall be subject to the reasonable discretion of the Manage=
ment
Board, except as otherwise provided in clause 4.3.4);
(c)&=
nbsp; &nbs=
p;
pay
within 30 days of such acceptance by the Management Board both:
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
i. &nb=
sp;
a
Joining Fee as specified in clause 7.2; and
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
ii. &n=
bsp;
any
of the Member's Annual Fees due for such financial year in which such Membe=
r is
admitted, as specified in clause 7.1 and subject to pro ration as set out in
clause 7.2.3;
(a)&=
nbsp; &nbs=
p;
demonstrates
fulfilment of the eligibility criteria set out in clause 4.3.2 of these Articles (irrespective of whether the Me=
mber
is a Charter Member or an Ordinary Member);
(b)&=
nbsp; &nbs=
p;
agrees
to be bound by these Articles (including its appendices), any other policie=
s or
other requirements specifically referred to in these Articles, and the Regu=
lations;
and
(c)&=
nbsp; &nbs=
p;
agrees
to assume all rights and obligations of the Member which it is replacing, in
relation to the Association and/or under those Articles and the other
instruments referred to in clause 4.4.1(b).
A Nominee shall, when admitted, be=
a
Member of the same membership category as the Member that it replaces (i.e.
Charter Member if replacing a Charter Member, and otherwise an Ordinary Mem=
ber).
(a)&=
nbsp; &nbs=
p;
the
Member is replaced by another Member in accordance with clause 4.4 of these Articles;
(b)&=
nbsp; &nbs=
p;
the
Member's membership is cancelled in accordance with clause 4.5.3 of these
Articles; or
(c)&=
nbsp; &nbs=
p;
the
Member's resignation is presented and takes effect in accordance with claus=
e 4.5.5
of these Articles.
(a)&=
nbsp; &nbs=
p;
the
Member:
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
i. &nb=
sp;
has
committed a material breach of these Articles, any other policies, instrume=
nts
or requirements referred to in these Articles, or the Regulations;
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
ii. &n=
bsp;
has in
a material respect acted in a manner detrimental to the Association or the
interests of the Association;
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
iii. &=
nbsp;
is
subject to an Insolvency Event, or becomes legally incapable of meeting the
obligations of a Member; or
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
iv. &n=
bsp;
fails
to pay any part of the Member's Fees (including accrued interest thereon) w=
hen
due, in the case of Fees other than the Annual Fee, or in the case of the
Annual Fee, by 30 June of the year in which such Annual Fee is due; and
(b)&=
nbsp; &nbs=
p;
the
Management Board has notified the Member in writing that it considers that =
an
event specified in paragraph (a) has occurred; and
(c)&=
nbsp; &nbs=
p;
in
the case of an event specified in sub-paragraphs (i) or (ii) of paragraph (=
a),
the breach or action is either incapable of remedy or is not remedied withi=
n 30
days following notice under paragraph (b); and
(d)&=
nbsp; &nbs=
p;
the
disputes resolution procedure set out in clause 15 of these Articles has been duly applied, if it has
been invoked; and
(f)&=
nbsp; &nbs=
p;
the Member has been given a reasona=
ble
opportunity to respond to the recommendation of the Management Board at the
meeting of the General Assembly in which the vote is taken.
(a)&=
nbsp; &nbs=
p;
not
be entitled to any reimbursement of fees or other monies paid by it to the
Association;
(b)&=
nbsp; &nbs=
p;
remain
obliged to pay any unpaid fees and other monies (including accrued interest
thereon) owing by it to the Association;
(c)&=
nbsp; &nbs=
p;
receive
no part of the assets of the Association; and
(d)&=
nbsp; &nbs=
p;
remain
bound by the obligations specified in clauses 5 of these Articles.
(a)&=
nbsp; &nbs=
p;
not
be entitled to any reimbursement of fees or other monies paid by it to the
Association;
(b)&=
nbsp; &nbs=
p;
remain
obliged to pay any unpaid fees and other monies (including accrued interest
thereon) owing by it to the Association;
(c)&=
nbsp; &nbs=
p;
receive
no part of the assets of the Association; and
(d)&=
nbsp; &nbs=
p;
remain
bound by any obligations specified in clause 5 of these Articles.
(a)&=
nbsp; &nbs=
p;
the
Association and each Member; and
(b)&=
nbsp; &nbs=
p;
the
Association and each Director and Executive of the Association,
and each such person agrees to be bound by the =
terms
of these Articles and to perform their obligations under these Articles.
(a)&=
nbsp; &nbs=
p;
to be
represented at, to participate fully in and to vote at meetings of the Gene=
ral
Assembly; and
(b)&=
nbsp; &nbs=
p;
to
nominate candidates for appointment to the Management Board, Committees and
Working Groups of the Association.
(a) =
is
entitled but, as set out in Article 4.1.6, not required to have its nominee
hold one of the positions on the Management Board until the conclusion of t=
he
first meeting of the General Assembly after
(b) =
may
remove or replace any such nominee from time to time at its own discretion.=
(a)&=
nbsp; &nbs=
p;
to
comply with the Regulations in force from time to time;
(b)&=
nbsp; &nbs=
p;
to
use best endeavours to ensure that any use, adaptation and distribution of =
the
Terminology Products and use of the Association's trade marks within the Me=
mber's
Territory is in accordance with these Articles (including the Intellectual
Property Terms);
(c)&=
nbsp; &nbs=
p;
to
pay within the required time, all Fees properly due to the Association in
accordance with these Articles;
(d)&=
nbsp; &nbs=
p;
to
confirm to the Association, at the same time as making each payment of its =
Annual
Fee, that the Member continues to meet the eligibility criteria specified in
clause 4.3.2 (irrespective of whether the Member is a Charter
Member or an Ordinary Member);
(f)&=
nbsp; &nbs=
p;
to
provide and publicise effective services allowing Affiliates and other expe=
rts
to provide recommendations for enhancements, changes, updates and correctio=
ns
to the Terminology Products in accordance with clause 5.4.1(e) of these Articles;
(g)&=
nbsp; &nbs=
p;
to
advise the Association of the contact details listed in Schedule 1 to
these Articles, and to provide the Association with timely advice of any ch=
ange
to such details;
(h)&=
nbsp; &nbs=
p;
to
maintain a register of all licences granted by the Member to Affiliates wit=
hin
the Member's Territory (to include, in the case of each licence, the identi=
ty
of the Affiliate the products provided under the licence and the payment te=
rms
under the licence), and to make that register available to the Association =
upon
request;
(i)&=
nbsp; &nbs=
p;
to
encourage experts and other appropriate persons to contribute to the work of
the Association;
(j)&=
nbsp; &nbs=
p;
to
assist the Association in communicating with Affiliates and experts entitled
and wishing to be enrolled as Affiliates of the Association;
(k)&=
nbsp; &nbs=
p;
to
collaborate with other Members in ensuring that sufficient numbers of
appropriate persons are nominated, supported and funded to serve on the
Management Board, Standing Committees and in other governance functions of =
the
Association;
(l)&=
nbsp; &nbs=
p;
to
ensure that:
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
i. &nb=
sp;
any person
nominated or appointed by the Member to serve on the Management Board, Stan=
ding
Committees and for other governance functions within the Association (a &qu=
ot;Nominated Person") have the
capacity, support and funding to perform those duties;
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
ii. &n=
bsp;
when
a Nominated Person of such Member is unavailable, and if so permitted by the
Articles and Regulations, a deputy, alternate or substitute is provided at =
such
Member's expense; and
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
iii. &=
nbsp;
there
is effective communication between any Nominated Person of a Member and any
wider stakeholder community from which the Nominated Person is drawn (in
particular, with representatives of other Members from Territories in the
Geographical Constituency (as defined in clause 9.1.4) that includes the
Territory of the Member who has appointed such Nominated Person).
(a)&=
nbsp; &nbs=
p;
being
the primary point of liaison with the Association with regard to all aspect=
s of
the management of the Terminology Products within the Member's Territory;
(b)&=
nbsp; &nbs=
p;
establishing
and maintaining processes for distributing and licensing the Terminology
Products within the Member's Territory;
(c)&=
nbsp; &nbs=
p;
being
the principal contact point within the Member's Territory for persons to
contact in relation to the Terminology Products, including licensing of the
Terminology Products and obtaining updates and enhancements to the Terminol=
ogy
Products;
(d)&=
nbsp; &nbs=
p;
ensuring
that any products and their releases that the Member deploys within its
jurisdiction that are based on the Association's Terminology Products, are
prepared, checked and managed in conformance with the Association's standar=
ds;
(e)&=
nbsp; &nbs=
p;
maintaining
a record of problems and other issues reported within the Member's Territor=
y in
connection with the Terminology Products;
(f)&=
nbsp; &nbs=
p;
documenting,
submitting and supporting requests for proposed updates and enhancements to=
the
Terminology Products; and
(g)&=
nbsp; &nbs=
p;
monitoring
the distribution and applications of the Association's Terminology Products,
trade marks and other Intellectual Property within the Member's Territory a=
nd
reporting to the Association on the same.
(a)&=
nbsp; &nbs=
p;
to
assist the Association in maintaining and enforcing any or all of its right=
s in
the Terminology Products, its trade marks and any of its other Intellectual
Property, and in protecting the same from any infringement, misrepresentati=
on,
passing off, unlicensed use, unlicensed adaptation or unlicensed distributi=
on
within the Member's Territory (each being a "Contravention");
(b)&=
nbsp; &nbs=
p;
to
assist the Association in protecting itself against any action to oppose, d=
eregister
or dispossess the Association of any part of its Terminology Products, trad=
e marks
or any of its other Intellectual Property especially but not exclusively wi=
thin
the Member's Territory;
(c)&=
nbsp; &nbs=
p;
to
assist the Association in protecting itself against any claim that any part=
of
the Terminology Products, trade marks or any of its other Intellectual Prop=
erty
infringes the rights of any third party in the Member's Territory;
(d)&=
nbsp; &nbs=
p;
to
notify the Association as soon as the Member becomes aware that:=
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
i. &nb=
sp;
a
Contravention;
= &nbs= p; &= nbsp; &nbs= p; &= nbsp; &nbs= p; ii. &n= bsp; any action described in paragraph (b) or any claim described in paragraph (c);<= o:p>
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
iii. &=
nbsp;
a
dispute with any third party (including any licensee) in the Member's Terri=
tory
concerning the Association's Terminology Products, its trade marks or any of
its other Intellectual Property;
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
iv. &n=
bsp;
any
claim or attempted registration in the Member's Territory of Intellectual
Property that competes with the Association's interests in its Terminology
Products, trade marks or any other of its Intellectual Property; or
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
v. &nb=
sp;
any
claim or allegation that any of the trade marks is liable to cause deceptio=
n or
confusion to the public within the Member's Territory,
&n=
bsp;  =
; has
occurred, is reasonably likely to occur or is threatened; and
(e)&=
nbsp; &nbs=
p;
to
provide all information and assistance to the Association in the event that=
the
Association commences or defends proceedings in relation to any matter list=
ed
in clause 5.5.1(d).
=
Any
external or out-of-pocket costs reasonably incurred by a Member in discharg=
ing
its obligations under this clause 5.5.1 shall be reimbursed by the Associat=
ion.
(a) the Association considers, acting reasonably, that the matter in respect of whi= ch the proceedings are brought presents or is likely to present a significant threat to the interests of the Association; or
(b) the m= atter in respect of which the proceedings are brought arise from the same or substantially the same facts and circumstances as one or more matters arisi= ng in one or more other Members’ Territories.
(a) assume control of those proceedings from the Member; or
(b) requi= re the Member to discontinue those proceedings.
(a)&= nbsp; &nbs= p; have the rights and oblig= ations in respect of the Association's Terminology Products that are set out in paragraph 6 of Schedule 3 to these Articles.
(b)&=
nbsp; &nbs=
p;
no
more than 14 Business Days after ceasing to be a Member, notify every Affil=
iate
with which the former Member has a license agreement in force for use of the
Terminology Products:
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
i. &nb=
sp;
that
it has ceased to be a Member;
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
ii. &n=
bsp;
that,
as a result of its ceasing to be a Member, it will be unable to distribute
future versions of the Association's Terminology Products to Affiliates;
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
iii. &=
nbsp;
of
any significant implications and proposed changes in arrangements for conti=
nued
use or support of the Terminology Products in the former Member's Territory;
and
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
iv. &n=
bsp;
of
any further statements that the Management Board has directed it to communi=
cate
to Affiliates provided that the content of any such statement is either fir=
st
agreed with the former Member, or is distributed under the name of the
Management Board along with any response from the former Member;
(c)&=
nbsp; &nbs=
p;
take
reasonable steps to minimise any unnecessary cost, damage or injury suffere=
d by
Affiliates within the former Member's Territory or by any other third parti=
es
as a result of the former Member ceasing to be a Member; and
(d)&=
nbsp; &nbs=
p;
give
all reasonable co-operation to the Association, Affiliates in the former Me=
mber's
Territory and any Member replacing the former Member in the former Member's
Territory (whether immediately pursuant to clause 4.4 or subsequently) in facilitating an orderly
transition of the former Member's Affiliates to such arrangements as are pu=
t in
place for those Affiliates' continued use or support of the Terminology
Products.
(a)&=
nbsp; &nbs=
p;
the
Purpose, Objects and Principles of the Association;
(b)&=
nbsp; &nbs=
p;
the
need to ensure that Affiliates and end-users of the Association's Terminolo=
gy
Products, trade marks and other Intellectual Property have access to effect=
ive
support and services in all Members' Territories;
(c)&=
nbsp; &nbs=
p;
the
need to protect the rights, property and reputation of the Association; and=
(d)&=
nbsp; &nbs=
p;
the
need to protect the rights and property of its other Members, including any=
new
Member in the former Member's Territory.
(a)&=
nbsp; &nbs=
p;
acquire
and obtain title to the
(b)&=
nbsp; &nbs=
p;
from
time to time consider and, where justified, acquire other Terminology Produ=
cts
including associated trade marks and other Intellectual Property required f=
or
their operation, exploitation, support and maintenance;
(c)&=
nbsp; &nbs=
p;
specify,
commission and/or directly provide the services necessary for undertaking
and/or supporting the development and maintenance of Terminology Products in
accordance with the Purpose, Objects and Principles of the Association;
(d)&=
nbsp; &nbs=
p;
provide
regular (at least twice yearly) International Releases of SNOMED CT;
(e)&=
nbsp; &nbs=
p;
provide
up-to-date documentation of other terminology products in line with specific
policies and procedures;
(f)&=
nbsp; &nbs=
p;
arrange
and support meetings of experts through Standing Committees and Working Gro=
ups;
(g)&=
nbsp; &nbs=
p;
produce,
manage and share all documentation to support the functions of the Associat=
ion
in line with specific requirements detailed in the Articles, regulations and
policies and procedures, in particular, those concerned with General Assemb=
ly,
Management Board, Harmonisation Bodies and Committee Meetings;
(h)
(i)&=
nbsp; &nbs=
p;
take
any action required to protect the rights, assets and property of the
Association in relation to the Terminology Products, trade marks and any ot=
her
Intellectual Property of the Association.
(a)&=
nbsp; &nbs=
p;
being
the primary point of liaison with the Association with regard to all aspect=
s of
the management of the international distribution of the Terminology Product=
s;
(b)&=
nbsp; &nbs=
p;
ensuring
the availability of
(c)&=
nbsp; &nbs=
p;
providing
a secure online collaboration facility to support Standing Committee and
Working Group activities and development of the Terminology Products.
(a) &nb= sp; As promptly as reasonably practicable of its receipt of a Defect Notice, and in any event within 60 days of such receipt, the Associa= tion will (i) notify the Member delivering the Defect Notice that the Work Defect has been remedied, or is in the process of being remedied, and provide an explanation of the steps that have been or are being taken in this regard, or (ii) noti= fy such Member either that the Association has determined either (x) that the work, product or service that was the subject of the Defect Notice is not defective or deficient in a material respect or (y) that it is not reasonably practical, or= not appropriate or consistent with= the interests of the Association, to remedy the defect or deficiency cited in the Defect Notice, and in either c= ase provide an explanation of such determination.
(b) &nb= sp; If the Association fails = to deliver any notice as required by clause 5.7.4(a), or if the Member receivi= ng such notice disagrees with the position taken by the Association in any such notice, the Member may (but i= s not required to) deliver a written demand to the Association (a “Defect Demand”) that steps or act= ions specified by the Member in its Defect Demand be taken by the Association (which may directly relate to remedying the relevant defect or deficiency or may involve changes in the policies, management or personnel of the Association) and that a meeting of the General Assembly be convened to adopt= a resolution requiring that such steps or actions are taken. If a Defect Demand is so rec= eived, an Extraordinary Meeting of the General Assembly for such purpose shall be convened as promptly as practical, in accordance with the notice and other requirements contained in clause 8.
(c) &nb= sp; All members of the Manage= ment Board shall, at a minimum and without limiting the roles or powers of the Management Board in any respect, receive copies of any Defect Notice, any notice by the Association in response to any Defect Notice, any Defect Dema= nd, and any related written communications between the Association and a Member= who have delivered a Defect Notice.
(d) &nb= sp; In the event that the Association fails in a material respect to take actions required to be take= n by it pursuant to clause 5.7.4 in response to the valid delivery of a Defect Notice or Defect Demand from a Member, and does not correct such failure within 30 days following notice thereof from such Member, then such Member may within 60 days thereafter re= sign from the Association in accor= dance with clause 4.5.5 and require that such resignation be treated as a resignation "for cause".<= span style=3D'mso-spacerun:yes'> A former Member whose resignation is treated as a resignation&nb= sp; "for cause" pursuant to the foregoing shall have the same rights and obligations as any other former Member who has resigned in accordance with clause 4.5.5 , provided that for purposes of paragraphs 6.1= .2 and 6.2 of Schedule 3 such former Member shall be deemed to have not ceased= to be a Member until the earlier of (a) the first anniversary of its resignati= on "for cause", and (b) the date (if any) on which paragraph 6.3 applies.
The Man=
agement
Board may waive the requirement in clause 6.2.3(a) with respect to the
recognition and designation of a Territory as a
(a)&=
nbsp; &nbs=
p;
a
draft of the Association's strategic, business and operational plans for su=
ch
next financial year;
(b)&=
nbsp; &nbs=
p;
a
statement of the total amount of funding required for such next financial y=
ear;
(c)&=
nbsp; &nbs=
p;
a statement
of the aggregate amount of the Annual Fees of all Members (before applying =
any Fee
Offsets) for such next financial year (the "Aggregate Annual Fee"), as proposed by the Management Boar=
d,
together with a schedule of the Annual Fee payable by each Member if the
Aggregate Annual Fee is approved by the General Assembly and the extent to
which the cash amount payable by any such Member in respect of its Annual F=
ee
will be reduced due to a Fee Offset requested by such Member and accepted by
the Management Board; and
(d)&=
nbsp; &nbs=
p;
information
regarding any Special Fees being proposed by the Management Board or then
expected to be proposed by the Management Board during such next financial =
year.
(a)&=
nbsp; &nbs=
p;
the normal
business activities of the Association to be undertaken in furtherance of t=
he
Purpose, Objects and Principles of the Association for the coming financial
year,
(b)&=
nbsp; &nbs=
p;
such
special projects as the Management Board considers appropriate to support t=
he
future development of the Association, its Intellectual Property and its ot=
her assets;
(c)&=
nbsp; &nbs=
p;
such
other projects or activities as are identified in the Association's strateg=
ic,
business and operational plans for the coming financial year;
(d)&=
nbsp; &nbs=
p;
fixed
or known liabilities of the Associations; and
(e)&=
nbsp; &nbs=
p;
reasonable
reserves for contingencies, liabilities and uncertainties that cannot be pr=
ecisely
budgeted for in advance.
The Aggregate Annual Fee shall be comprised of =
the aggregate
cash amounts paid or payable by Members in respect of their Annual Fees, pl=
us
any amounts not payable or paid in cash due to the application of Fee Offse=
ts. The Aggregate Annual Fee shall be
allocated among the Members pursuant to a Fair Share Allocation (as specifi=
ed
in Schedule 2 to these Articles).&nbs=
p;
The amount allocated to each Member will be such Member's Annual Fee=
.
(a)&=
nbsp; &nbs=
p;
Electronic
draft copies of these minutes will be prepared by or at the direction of the
Chair and sent to Members within 14 days of the close of the meeting.
(b)&=
nbsp; &nbs=
p;
Members
may submit any comments on the minutes within 14 days of receipt.
(c)&=
nbsp; &nbs=
p;
The
Chair shall seek to promptly address or resolve such comments so received w=
ith
a view towards signing and circulating final copies of the minutes to all
Members within 14 days of expiry of the period allowed for Members' comment=
s.
(d)&=
nbsp; &nbs=
p;
The
signed final minutes shall be made available to the public by posting them =
on
the Association's website. The signed final copy of the minutes shall also =
be
made available for inspection at the Association's place of business.
(a)&=
nbsp; &nbs=
p;
the
Management Board; or
(b)&=
nbsp; &nbs=
p;
the
External Financial Auditor; or
(c)&=
nbsp; &nbs=
p;
one-third
of all Members if such request, together with an agenda setting out the
specific business to be dealt with at the Extraordinary Meeting, is deliver=
ed
in writing to the Management Board.
(a)&=
nbsp; &nbs=
p;
have
specific business or matters referred for discussion by or decision of the =
General
Assembly;
(b)&=
nbsp; &nbs=
p;
attend
meetings of the General Assembly; and
(c)&=
nbsp; &nbs=
p;
speak
at such meetings.
(a)&=
nbsp; &nbs=
p;
the
public discussion or disclosure of which is or may be contrary to the inter=
ests
of the Association; or
(b)&=
nbsp; &nbs=
p;
relate
to an individual or a specific Member who could be identified by members of=
the
public.
(a)&=
nbsp; &nbs=
p;
the
presentation and adoption of:
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
i. &nb=
sp;
the Management
Board's annual strategic, business and operational plans for the next finan=
cial
year; and
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
ii. &n=
bsp;
the Management
Board's proposed Aggregate Annual Fee for the next financial year.
(b)&=
nbsp; &nbs=
p;
the
election of the:
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
i. &nb=
sp;
the
members of the Management Board (other than those appointed pursuant to
clause 9.1.3) whose terms are then expiring;
=
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
ii. &n=
bsp;
those
members of any Committees (other than who are not required to be elected by=
the
General Assembly) whose terms are then expiring;
(c)&=
nbsp; &nbs=
p;
any
general or special business referred to the General Assembly by the Managem=
ent
Board for consideration in the Ordinary Meeting; and
(d)&=
nbsp; &nbs=
p;
any
other business referred to the General Assembly by any Member for considera=
tion
in the Ordinary Meeting.
(a)&=
nbsp; &nbs=
p;
the Management
Board's annual report for the prior financial year;
(b)&=
nbsp; &nbs=
p;
the Association's
financial accounts, including the External Financial Auditor's Report for t=
he
prior financial year;
(c)&=
nbsp; &nbs=
p;
the appointment
of (or ratification of the appointment of) an External Financial Auditor for
the current financial year;
(d)&=
nbsp; &nbs=
p;
any
general or special business referred to the General Assembly by the Managem=
ent
Board for consideration in the Ordinary Meeting; and
(e)&=
nbsp; &nbs=
p;
any
other business referred to the General Assembly by any Member for considera=
tion
in the Ordinary Meeting.
(a)&=
nbsp; &nbs=
p;
concerning
the annual accounts or the financial position of the Association;
(b)&=
nbsp; &nbs=
p;
the
status or progress of any legal issues or proceedings relevant to the
Association or its Intellectual Property;
(c)&=
nbsp; &nbs=
p;
that
is or may be relevant to any resolution on which a vote is to be taken at t=
hat
General Assembly meeting.
(a)&=
nbsp; &nbs=
p;
the
issue has not been adequately addressed by Management Board action to the r=
easonable
satisfaction of the Member, and
(b)&=
nbsp; &nbs=
p;
the
Member submits a specific and reasonably detailed written request to the
Management Board no less than three weeks (or such shorter period as the
Management Board may require in any particular instance) in advance of the
General Assembly meeting.
(a)&=
nbsp; &nbs=
p;
Each
Charter Member shall be entitled to appoint one Director and one substitute=
for
such Director to the Management Board.
(b) &nb= sp; An appointed Director's substitute may attend meetings of the Management Board= when the Director cannot attend, and in such circumstances the substitute will h= ave the same rights and obligations as the appointed Director.
(c)&=
nbsp; &nbs=
p;
Each
Ordinary Member shall be entitled to nominate a person for election as Dire=
ctor
to the Management Board and nominate a person for election as substitute to=
the
Management Board.
(d)&=
nbsp; &nbs=
p;
In
the event that there would be one or more vacant positions in the Managemen=
t Board
assuming the election of all persons nominated pursuant to clause 9.1.3. (c=
),
each Charter Member will be entitled to nominate a maximum of two persons e=
ach
for election to fill such vacancy.
(e)&=
nbsp; &nbs=
p;
In
the event that there would be one or more vacant positions in the Management
Board assuming the election of all persons nominated pursuant to clause 9.1=
.3 (c)
and (d), each Charter Member and each Ordinary Member will be entitled to n=
ominate
a
(f)&=
nbsp; &nbs=
p;
In
the event that there would be one or more vacant positions in the Management
Board assuming the election of all persons nominated pursuant to clause 9.1=
.3 (c)-(e),
the appointed Management Board members may nominate persons for election to
fill such vacancy, whether from internal and external sources, whom such
members reasonably believe has competent or relevant experience and/or
expertise and can be expected to appropriately and adequately contribute to=
the
Management Board's discharge of its functions and duties.
(g)&=
nbsp; &nbs=
p;
Once
each Charter Member has exercised its right to appoint a Director to the
Management Board (or waived its right to do so), the General Assembly, in i=
ts Ordinary
Meeting, shall elect the remaining Directors from among the persons nominat=
ed
pursuant to clause 9.1.3(c)-(f).
(h)&=
nbsp; &nbs=
p;
Any
person nominated for election as a Director may, but shall not be required =
to,
be nominated together with a person who will serve as the substitute for th=
at
Director. An elected Director's substitute may attend meetings of the
Management Board when the Director cannot attend, and in such circumstances=
the
substitute will have the same rights and obligations as the appointed Direc=
tor.
(i) &nb= sp; If an elected Director, as per clause 9.1.3 (c)-(g), resigns from the Management Board or otherwise ceases to be a Director before the end of her term, the substitute of the Director (if any), shall replace her as Director and if t= here is no such substitute, such vacancy shall be filled by a person appointed by the Management Board.
(j) &nb= sp; If a Director appointed b= y a Charter Member, as per clause 9.1.3(a), resigns from the Management Board or otherwise ceases to be a Director before the end of her term, the substitut= e of the Director (if any), shall replace her.
(k) &nb= sp; If there is no such subst= itute or if the Charter Member who appointed such Director prefers otherwise, such vacancy will be filled by a person appointed by such Charter Member.=
(a)&=
nbsp; &nbs=
p;
(b)&=
nbsp; &nbs=
p;
the
(c)&=
nbsp; &nbs=
p;
(d)&=
nbsp; &nbs=
p;
Asia
and
=
(a)&=
nbsp; &nbs=
p;
Each Member will be entit=
led to
nominate one candidate on behalf of such Member's Geographical Constituency=
.
=
(b)&=
nbsp; &nbs=
p;
At the meeting of the Gen=
eral
Assembly in which Directors are to be elected, each Member will be entitled=
to
vote for up to twelve nominees, provided that in no event will a Member be
entitled to cast more than one vote for any nominee.
=
(c)&=
nbsp; &nbs=
p;
The nominees elected to
Director will be the three nominees for each Geographical Constituency who
receive the highest number of votes among all the nominees from such
Geographical Constituency.
=
(d)&=
nbsp; &nbs=
p;
In the event that there a=
re
less than three nominees for a Geographical Constituency, then the vacancy =
that
would result there from will be filled by the nominee for any other
Geographical Constituency who received the highest number of votes but was =
not
elected as a Director pursuant to the foregoing.
=
(e)&=
nbsp; &nbs=
p;
In the event that any Dir=
ector
resigns from the Management Board or otherwise ceases to be a Director befo=
re
the end of her term as a Director, the vacancy resulting there from will be
filled by an appointment of a successor Director by the Management Board, w=
ith
such successor Director being a person representing the same Geographical
Constituency as the person who resigned or ceased to be a Director, except =
in
the case of the resignation of a Director elected pursuant to clause 9.1.5 =
(d).
=
(f)&=
nbsp; &nbs=
p;
In the event of the resig=
nation
of a Director elected pursuant to clause 9.1.5 (d) the vacancy will be fill=
ed
by an appointment of a successor Director by the Management Board, with such
successor Director being a person representing the Geographical Constituency
with the lowest representation of Directors. If there is no one such
Geographical Constituency, then the Management Board shall appoint such per=
son
as it deems most appropriate for the appointment irrespective of their
Geographical Constituency.
= The term of all Directors will expire upon the election of members of the Management Board of the Ordinary Meeting of the General Assembly in October 2012. In the election of the members of = the Management Board in October 2012, the Directors elected who were nominees of the Geographical Constituencies of Africa and the Americas will have an ini= tial term of one year, such that in each year after 2012 Directors on behalf of = only two of the four Geographical Constituencies, on an alternating basis, will = be up for election. If a Director resigns or otherwise ceases to be a Director before the expiration of her t= erm, the person replacing her (regardless of how appointed) will have a term as a Director continuous with, and expiring at the same time as, the Director who she replaced.
(a)&=
nbsp; &nbs=
p;
at
least four times per year, at least one of which will be held in
(b)&=
nbsp; &nbs=
p;
as
requested by two or more appointed Directors;
(c)&=
nbsp; &nbs=
p;
as
requested by the Chief Executive Officer; and
(d)&=
nbsp; &nbs=
p;
as
frequently as the Chair of the Management Board considers appropriate.
(a)&=
nbsp; &nbs=
p;
formal
minutes of Management Board meetings are recorded, circulated to Management
Board members in draft, discussed, amended as necessary, agreed at the next
meeting of the Management Board and signed by the Chair;
(b)&=
nbsp; &nbs=
p;
the
minutes contain a record of all Directors present either physically or by
alternative means;
(c)&=
nbsp; &nbs=
p;
any
Director who does not agree to a resolution at the time it is made by the
Management Board is entitled to have her dissenting views recorded in the
minutes; and
(d)&=
nbsp; &nbs=
p;
minutes
of meetings of the Management Board are published on the Association's webs=
ite,
except those parts of the minutes of the Management Board which include
information or materials of the type referred to in paragraphs (a) or (b) of
clause 8.2.14 of these Articles.
(a)&=
nbsp; &nbs=
p;
a
Chief Executive Officer;
(b)&=
nbsp; &nbs=
p;
a
Chief Financial Officer;
(c)&=
nbsp; &nbs=
p;
a
Chief Terminologist;
(d)&=
nbsp; &nbs=
p;
a
Chief Technical Architect;
(e)&=
nbsp; &nbs=
p;
a
Chief Quality Assurance Officer; and
(f)&=
nbsp; &nbs=
p;
a
Chief Research and Innovation Officer.
A person can hold more than one of these positi=
ons at
any one time, except that a single person may not hold the positions of Chi=
ef
Executive Officer and Chief Financial Officer simultaneously. Although not
generally intended, Directors may be appointed to hold one or more of these=
positions
on a temporary basis.
The
Association can enter into agreements obliging the other party to provide o=
ne
of its employees to hold a position as Executive Officer in the Association=
on
behalf of the other party. Such agreements can not be entered into regarding
the position as Chief Executive Officer.
(a)&=
nbsp; &nbs=
p;
ensure any work has:
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
i. &nb=
sp;
a robust and detailed requirement
including a development plan which describes the deliverables and the timin=
g of
their production;
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
ii. &n=
bsp;
a detailed specification of the
product(s);
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp;
iii. &=
nbsp;
clear implementation guidance in all
the necessary domains, which may include the clinical,
managerial/organisational and technical communities;
&nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp;
iv. &n=
bsp;
any conformance criteria to assess
whether the standard has indeed been implemented appropriately;
(b)&=
nbsp; &nbs=
p;
develop any rules, undertakings or
arrangements regarding whether and how
(c)&=
nbsp; &nbs=
p;
represent both organisations;
(d)&=
nbsp; &nbs=
p;
provide overall management and gove=
rnance
of joint work;
(e)&=
nbsp; &nbs=
p;
clarify and describe the Intellectu=
al
Property implications of the joint work; and
(f)&=
nbsp; &nbs=
p;
secure funding for the joint work,
including its initiation, creation and maintenance.
(a)&=
nbsp; &nbs=
p;
Standing
Committees; and
(b)&=
nbsp; &nbs=
p;
Ad
hoc committees.
(a)&=
nbsp; &nbs=
p;
the
Content Committee, as defined in clause 9.5;
(b)&=
nbsp; &nbs=
p;
the
Technical Committee, as defined in clause 9.6;
(c)&=
nbsp; &nbs=
p;
the
Research and Innovation Committee, as defined in clause 9.7; and
(d)&=
nbsp; &nbs=
p;
the
Quality Assurance Committee, as defined in clause 9.8.
(a)&=
nbsp;
sent
by electronic communication to an address for the time being notified to the
Association by that person for that purpose;
(b)&=
nbsp;
published
on a web site, provided that the following conditions are met:
&nbs=
p; &=
nbsp; &nbs=
p;
I. &nb=
sp;
the Association
and that person have agreed that such documents may be accessed by her on a=
web
site (instead of their being sent by post or otherwise delivered to her); a=
nd
&nbs=
p; &=
nbsp; &nbs=
p;
II. &n=
bsp;
that
person is notified, in a manner for the time being agreed for the purpose
between her and the Association of:
A.&n=
bsp;
the
publication of the documents on a web site;
B.&n=
bsp;
the
address of that web site;
C. the place on that web site where the documents may be accessed; and
D.&n=
bsp;
how such documents may be
accessed.
(a)&=
nbsp; &nbs=
p;
the
Articles;
(b)&=
nbsp; &nbs=
p;
name
and addresses of the members of the Management Board;
(c)&=
nbsp; &nbs=
p;
name
and addresses of the executive directors;
(d)&=
nbsp; &nbs=
p;
powers
to sign the Association, as per clause 9.13;
(e)&=
nbsp; &nbs=
p;
name,
address and home municipality of the Association;
(f)&=
nbsp; &nbs=
p;
financial
year of the Association;
(g)&=
nbsp; &nbs=
p;
name
of the Association's External Financial Auditor.
(a)&=
nbsp; &nbs=
p;
electronically
despatched notice of the Regulation to all Members, advising them of the
Regulation and the impact of any changes; and
(b)&=
nbsp; &nbs=
p;
updated
the version of the Regulations publicly available through the Association's
website.
The Members shall, and shall use their respecti=
ve
reasonable endeavours to procure that any necessary third parties shall, do,
execute and perform, at their own expenses, all things reasonably necessary=
to
give full force and effect to these Articles and any transaction contemplat=
ed
by them.
If
any part of any provision of these Articles shall be held by any court of
competent jurisdiction to be unenforceable against or by the Association, s=
uch
part shall be treated as being severable from the rest of these Articles and
the validity, legality and enforceability of the remaining provisions shall=
not
in any way be impaired.
17.1.1
In
these Articles, unless the contrary intention appears:
‘Ad hoc Committee’ has the =
meaning
set out in clause 9.9 of these Articles;
'Affiliate(s)' ha=
s the
meaning set out in clause 6.1.1 of these Articles;
‘Aggregate Annual Fee’=
has the=
meaning
set out in clause 7.1.1(c) of these Articles;
'Aggregate Special Fee'=
has the meaning set out at clause=
7.5.1
of these Articles;
'Annual
Fee' has the mean=
ing as
set out at clause 7.1 of these Articles;
‘Annual
Report’ mea=
ns the Association’s
balance sheet prepared in accordance with clause 9.10 and audited by the
Association’s External Financial Auditor;
‘Approved
Direct Set-up Costs’ has
the meaning set out in clause 7.6.4 of these Articles;
'Articles' means these Articles of Associati=
on and
incorporates the schedules and appendices;
'Association' has the meaning give=
n to
it in clause 1.1 of these Articles;
'Business
Day' means, in re=
lation
to the doing of any action in a place, a weekday other than a public holida=
y or
bank holiday in that place;
'Business
Hours' means from=
9.00 am
to 5.00 pm on any Business Day;
‘Chair’
means a natural p=
erson
who presides over a meeting as required under these Articles;
'Charter Members' have the meaning as set out at clause 4.2 of these Articles; <= o:p>
'Committee'
means an Ad hoc C=
ommittee
or a Standing Committee;
'Conflicts
of Interest Policy' is a policy
to be established by the Management Board and approved by the General Assem=
bly,
containing the rules and procedures governing certain potential conflicts of
interest relating to the Association;
'Contravention'
has the meaning g=
iven in
clause 5.5.1(a) of these Articles;
‘Direct Set-=
Up Costs’
has the meaning set out in clause 7.6.4 of th=
ese
Articles;
'Director' means a natural person that parti=
cipates
in the management of the Association as a member of the Management Board wh=
ile
that person remains a member of the Management Board and includes a former
director so far as any matter relates to their participation while a member=
of
the Management Board;
'Executive' and 'Executive
Officer' means a Chief Executive Officer and any other person that is
appointed to a named executive position or is directly responsible for
conducting the affairs of the Association including without limitation:
(a) appointment
and direction of the Association's personnel;
(b) managing
the Association's finances and assets;
(c) managing
the Association's property (including its Intellectual Property);
(d) conducting
the Association's business dealings with others;
(e) ensuring
the Association's compliance with its legal obligations; and
(f) making
public statements and representations on behalf of the Association;
‘External
Financial Auditor’ means the
Danish state-authorised public accountant from an international accounting =
firm
referred to in clause 9.10.4;
'Fee' means the Annual Fee and the Join=
ing Fee,
or either of them;
'Fee
Offset' has the m=
eaning
set out in clause 7.6.1 of these Articles;
'Fee
Offset Balance' has the meaning set out in clause 7.6.2 of these Articles;
'General
Assembly' has the meaning as set out in clause 8 of these Articles;
‘Geographical
Constituency’ has
the meaning set out in clause 9.1.4 of these Articles;
‘Harmonisation
Body’ has t=
he
meaning set out in clause 9.3 of these Articles;
'Insolvency
Event' means, in =
respect
of any Member, any of the following events in relation to that Member: (a) =
that
Member becoming insolvent or unable to pay its debts as they fall due; (b) =
that
Member suspending or ceasing payment of any of its debts, or threatening to=
do
so, or a moratorium being imposed in respect of that Member's indebtedness;=
(c)
that Member proposing or making an arrangement, assignment, composition or
compromise with or for the benefit of its creditors; (d) a liquidator,
receiver, administrator, manager or similar official or any encumbrancer be=
ing
appointed over that Member or any of its assets or undertaking; (e) the adm=
inistration,
winding up, bankruptcy or dissolution of that Member, or any petition or
application being presented for the same; or (f) anything analogous to any =
of
the events described in (a) to (e) in any jurisdiction;
'Intellectual
Property' or 'IP' includes all copyright (incl=
uding
rights in relation to phonograms and broadcasts), database rights, all righ=
ts
in relation to inventions (including patents), plant varieties, trade marks
(including service marks), designs, circuit layouts, all other rights resul=
ting
from intellectual activity in the industrial, scientific, literary or artis=
tic
fields and any right to have confidential information kept confidential, but
does not include moral rights or rights of performers;
'Intellectual
Property Rights' means the rights of an owner of Intellectual Prop=
erty
and includes the right to register or enforce such rights wherever they exi=
st
throughout the world;
'Intellectual
Property Terms' m=
eans the
terms set out in Schedule 3 to these Articles;
‘Internal
Auditor’ me=
ans a
person elected by the General Assembly from among Members, as per clause 8.=
1.3,
to assist the General Assembly in discharging its role, following terms of
reference set or developed by or at the direction of the General Assembly. =
‘ISDO’
means
'Jo=
ining
Fee' has the meaning as set out in clause 7.2 of these Articles;
'Management
Board' has the me=
aning
given in clause 9.1 of these Articles;
'Member'
has the meaning as set out in clause 4.1.1 of these Articles;
'NLM' means National Librar=
y of
Medicine;
'Nominated
Person' has the meaning set out in clause 5.4.1 (l) of these Articles; =
'Nominated
Representative' i=
s the
person who is registered by the Association as the representative of a Memb=
er
at General Assemblies;
'
'Ordinary
Meeting' means the annual meeting of the General Assembly in either Oct=
ober
or April of every year;
'Ordinary Members' have the meaning as set out at clause 4.3 of these Articles; <= o:p>
'Party' in relation to these Articles mea=
ns the
Association or a Member and 'Parties' means any or all of them;
'Purpose'
has the meaning set out in clause 2.1 of these Articles;
'Principles'
has the meaning set out in clause 2.3 of these Articles;
'Regulations' means Regulations of the Associat=
ion made
by the Management Board under clause 11;
'Set-up
'
'Special Fee' has the m=
eaning
set out in clause 7.5.1 of these Articles;
'Special Fee Proposal'<=
/span> has the m=
eaning
set out in clause 7.5.2 of these Articles;
'Sponsored <=
b>Territory' has the meaning set out in clause 6 of these Articles;
‘Sponsored Territ=
ory
Fee’ has the meaning set out in clause 6=
.2.3
(c) of these Articles;
'Standing
Committee' means =
any of
the Standing Committees provided for in clauses 9.4, 9.5, 9.6, 9.7 and=
9.8;
'Super
Majority' means, =
in
respect of any resolution tabled in a meeting of the General Assembly, that=
the
number of Members voting in favour of the resolution is more than two third=
s of
all Members present at the meeting and also more than half of all Members
(whether present at the meeting or not);
'Terminology
Products' has the=
meaning
given in clause 2.1.1(a), and a reference in these Articles to the Terminol=
ogy
Products includes any and all further versions, enhancements, upgrades and
extensions of the Terminology Products from time to time;
'Territory' means, subj=
ect to
clause 4.1.3, the Principal Nation for or in respect to which a Member has =
been
or may be admitted as a member of the Association, together with any other
country, nation, state or geographical area which has been or may be deemed=
to
be included in such Territory for which such Member has been or may be admi=
tted
as a member of the Association as permitted by clause 4.1.4. A Territory shall further be
deemed to include, in respect of its Principal Nation and any country, nati=
on
or state included in the Territory pursuant to clause 4.1.4, any and all of=
its
or their governmental facilities or offices, whether permanent or temporary=
and
wherever located, and any other locations otherwise outside of such Territo=
ry
where personnel or agents of any such governments are engaged in activities=
by,
on behalf of or at the direction of any of such governments (provided that =
any
such location shall be deemed within a Territory only for purposes of such
activities).
'Working
Groups' has the meaning given under clause 9.4.8 of these Articles.
(a) the
singular includes the plural and vice versa, and a gender includes other
genders;
(b) another
grammatical form of a defined word or expression has a corresponding meanin=
g;
(c) a
reference to an article, clause, paragraph, schedule or appendix is a refer=
ence
to an article, clause or paragraph of, or schedule or appendix to, these
Articles;
(d) a
reference to a document or instrument includes the document or instrument as
novated, altered, supplemented or replaced from time to time;
(e) a
reference to 'US$', '$
(f) a
reference to a Party to a document (including these Articles) includes the
Party's executors, administrators, successors and permitted assigns and
substitutes;
(g) a
reference to a person includes a natural person, partnership, body corporat=
e,
association, governmental or local authority or agency or other entity;
(h) reference
to a statutory provision includes a reference to the statutory provision as
modified or re-enacted or both from time to time before the date of these
Articles and any subordinate legislation made under the statutory provision=
(as
so modified or re-enacted) before the date of these Articles;
(i) the
meaning of general words is not limited by specific examples introduced by =
'including',
'for example' or similar expressions;
(j) a
rule of construction does not apply to the disadvantage of a Party because =
the
Party was responsible for the preparation of these Articles or any part of
them;
(k) if
a day on or by which an obligation must be performed or an event must occur=
is
not a Business Day, the obligation must be performed or the event must occu=
r on
or by the next Business Day;
(l) the
headings in these Articles do not affect its interpretation;
(m) references
to the time of day are to the time in
(n) references
to writing include electronic mail and any other mode of representing words=
in
a visible form, provided that it is possible to record and reproduce that
representation.

Adopted at the Statutory General Assembly of the Association on
&=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p; &=
nbsp; &nbs=
p;
Advokat Martin Habersaat
Chair at the Extraordinary General
Assembly on
(a) Full
Legal name of Member
(b) Member's
trading names (if different)
(c) Member's
business registration number(s) and Issuing authority/authorities
(d) Address
of Registered Office
(e) Name
and title of contact person authorised to receive notices
(f) Contact
person's telephone number(s)
(g) Contact
person's email address
(h) Postal
Address for service of notices on the Member
(i) Facsimile
number for service of notices on the Member
(j) Office
telephone number
(k) Name
of Chief Executive Officer
(l) URL
of Member's main website
And wherever relevant:
(m) Name
of Executive(s) with responsibility for maintenance and distribution of
Terminology Products
(n) URL(s)
advising how third parties may obtain rights to use Terminology Products
(o) Name
and shipping address of the office of the person dealing with the arrangeme=
nts
for national release
(p) Contact
name and title of the person dealing with the arrangements for national rel=
ease
(q) Telephone
number of the person dealing with the arrangements for national release
(r) Email
address of the person dealing with the arrangements for national release
(s) Name
and address of the Nominated Representative at any given time.
The information set out below will=
be
published on the Association website.
1.<=
span
style=3D'font:7.0pt "Times New Roman"'> Fair Share Allocat=
ion of
fees
Each Aggregate Annual Fee and any Aggregate Special Fee shall be
allocated amongst the Members on a fair-share allocation basis as described
below ("Fair Share Allocation=
").
Individual Member's Fee = =3D &= nbsp; Aggregate Fee ´ (MGNI / AGNI)
Where:
Aggregate Fee =3D = the amount of the Aggregate Annual Fee or Aggregate Special Fee, as applicable<= /span>
MGNI &n= bsp;  = ; = =3D &= nbsp; the World Bank GNI Atlas value of the individual Member
AGNI &n= bsp;  = ; <= /span>=3D &= nbsp; the aggregate of the World Bank GNI Atlas values of all Members
Appendix 1 sets out the current World Bank GNI Atlas values for each
nation. Appendix 1 will be re=
vised
every third 30 September, commencing 30 September 2010, with the most curre=
nt
World Bank GNI Atlas values then published by the World Bank. Should the World Bank discontinue =
the
GNI Atlas values then the Management Board shall propose an alternative met=
ric
to the General Assembly for approval.
Should a nation not have a World Bank GNI Atlas value then that nati=
on
shall propose a value to the Management Board for use in place of a World G=
NI
Atlas Bank value and shall submit the relevant economic data and supporting
assumptions. The Management B=
oard
shall have absolute discretion as to the determination of the alternative v=
alue
to use in place of a World Bank GNI Atlas value.
2.<=
span
style=3D'font:7.0pt "Times New Roman"'> Fair Share Allocat=
ion of
Fee Offset Balances
For purposes= of clause 7.6.1, the acceptance of requests for Fee Offsets in respect of a specific = Fee shall be allocated in such a manner so as to equalise, among the Members re= questing Fee Offsets in respect of such specific Fee, the Fee Offset Balance divided= by the World Bank GNI Atlas value of each Member, starting with the Member with the highest such ratio.
3.<=
span
style=3D'font:7.0pt "Times New Roman"'> Initial Annual Fee=
s of
Charter Members
The Annual Fee of each Charter Member in 2007 shall be payable on 27
April 2007, or on such later date as the Management Board may specify provided that such initial Annual Fee shall in no event be due=
and
payable prior to the execution of a definitive agreement between the Associ=
ation
and
Table 1: 2007 Annual Fee Payments<= o:p>
|
Charter Member |
2007 Annual Fee |
|
|
193,924 |
|
|
324,523 |
|
|
78,628 |
|
|
7,069 |
|
The |
184,598 |
|
|
29,550 |
|
|
115,171 |
|
|
722,555 |
|
|
4,354,167 |
|
Total |
6,010,185 |
*In recognition of the fees already paid by the NLM to the College of
American Pathologists for the period ending 30 June 2007 under the licence
agreement transferred from the College of American Pathologists to the
Association, seven nineteenths (7/19) of the value of the fee set out in Ta=
ble
1, shall be considered to have already been paid in cash by NLM to the
Association. Unless otherwise provided in an applicable Member Contract, the
balance of the
4.<=
span
style=3D'font:7.0pt "Times New Roman"'> Set-up Payment
On establishment of the Associatio=
n the
Charter Members will make payments to the Association as described in Table=
2
to enable the Association to purchase the SNOMED CT IP from the
Table 2: Charter Member Set-up Payments
|
Charter Member |
Set-up Payment (US Dollars) |
|
|
1,100,000 |
|
|
785,401 |
|
|
170,692 |
|
|
10,789 |
|
The |
398,343 |
|
|
107,776 |
|
|
248,527 |
|
|
5,427,741 |
|
|
0 |
|
Total |
8,249,269 |
5. Direct Set-Up Costs
Table 3: Direct Set-up costs
|
Charter Member |
Description of cost items<= /p> |
Agreed Estimate (US Dollars) |
|
|
Swiss legal costs incurred to inv=
estigate
formation of Swiss Foundation, including the cost of developing draft Dee=
d of
Foundation; |
561,635.17 |
|
|
Danish legal costs incurred to dr= aft and comment on Articles and other documentation, and to provide tax advice; a= nd any and all legal registration fees, bank fees or similar fees/expenses (including miscellaneous out of pocket expenses) incurred to form and establish the Association as a legal entity. |
150,000.00 |
Appendix 1
World Bank GNI Atlas values
As published at http://www.world=
bank.org
in September 2005.
|
Country |
World Bank GNI Atlas value ($US) |
|
|
|
6,641,208,000 |
|
|
|
73,675,930,000 |
|
|
|
14,440,830,000 |
|
|
|
800,392,000 |
|
|
|
142,337,900,000 |
|
|
|
3,423,703,000 |
|
|
|
541,173,500,000 |
|
|
|
262,147,400,000 |
|
|
|
7,828,371,000 |
|
|
|
61,229,650,000 |
|
|
|
20,856,440,000 |
|
|
|
322,837,000,000 |
|
|
|
1,114,831,000 |
|
|
|
3,666,842,000 |
|
|
|
677,244,200 |
|
|
|
8,656,203,000 |
|
|
|
7,841,470,000 |
|
|
|
7,489,853,000 |
|
|
|
552,096,300,000 |
|
|
|
21,326,420,000 |
|
|
|
4,435,568,000 |
|
|
|
669,446,100 |
|
|
|
4,429,573,000 |
|
|
|
13,138,250,000 |
|
|
|
905,628,500,000 |
|
|
|
851,677,100 |
|
|
|
1,225,836,000 |
|
|
|
2,276,813,000 |
|
|
|
78,407,490,000 |
|
|
|
1,676,846,000,000 |
|
|
|
90,625,850,000 |
|
|
|
327,567,300 |
|
|
|
6,416,269,000 |
|
|
|
2,973,813,000 |
|
|
|
18,968,740,000 |
|
|
|
13,263,430,000 |
|
|
|
29,699,650,000 |
|
|
|
13,633,390,000 |
|
|
|
93,154,710,000 |
|
|
|
219,422,200,000 |
|
|
|
739,066,700 |
|
|
|
261,183,800 |
|
|
|
18,442,810,000 |
|
|
|
28,782,720,000 |
|
|
|
90,128,690,000 |
|
|
|
15,613,370,000 |
|
|
|
806,049,500 |
|
|
|
9,434,671,000 |
|
|
|
7,747,229,000 |
|
|
|
2,280,977,000 |
|
|
|
171,023,500,000 |
|
|
|
1,858,731,000,000 |
|
|
|
5,415,070,000 |
|
|
|
413,693,200 |
|
|
|
4,683,333,000 |
|
|
|
2,488,974,000,000 |
|
|
|
8,090,398,000 |
|
|
|
183,916,900,000 |
|
|
|
397,261,200 |
|
|
|
26,945,200,000 |
|
|
|
3,681,113,000 |
|
|
|
250,229,000 |
|
|
|
765,392,800 |
|
|
|
3,380,033,000 |
|
|
|
7,320,814,000 |
|
|
|
183,516,000,000 |
|
|
|
83,314,620,000 |
|
|
|
11,199,210,000 |
|
|
|
674,580,300,000 |
|
|
|
248,006,600,000 |
|
|
|
153,983,800,000 |
|
|
|
137,761,300,000 |
|
|
|
118,123,500,000 |
|
|
|
1,503,562,000,000 |
|
|
|
7,737,844,000 |
|
|
|
4,749,910,000,000 |
|
|
|
11,628,520,000 |
|
|
|
33,779,570,000 |
|
|
|
14,987,320,000 |
|
|
|
95,048,130 |
|
|
|
673,035,900,000 |
|
|
|
2,050,307,000 |
|
|
Lao PDR |
2,239,224,000 |
|
|
|
12,569,510,000 |
|
|
|
22,668,260,000 |
|
|
|
1,335,951,000 |
|
|
|
390,846,600 |
|
|
|
25,256,770,000 |
|
|
|
19,726,720,000 |
|
|
|
25,301,790,000 |
|
|
|
4,854,931,000 |
|
|
|
5,181,221,000 |
|
|
|
1,922,145,000 |
|
|
|
117,132,200,000 |
|
|
|
752,442,500 |
|
|
|
4,334,956,000 |
|
|
|
4,913,202,000 |
|
|
|
142,084,000 |
|
|
|
1,210,344,000 |
|
|
|
5,730,178,000 |
|
|
|
703,080,100,000 |
|
|
|
251,907,100 |
|
|
|
2,563,420,000 |
|
|
|
1,484,228,000 |
|
|
|
46,517,850,000 |
|
|
|
4,709,901,000 |
|
|
|
4,813,463,000 |
|
|
|
6,538,012,000 |
|
|
|
515,147,600,000 |
|
|
|
82,464,930,000 |
|
|
|
4,452,097,000 |
|
|
|
2,836,014,000 |
|
|
|
53,982,560,000 |
|
|
|
238,398,000,000 |
|
|
|
90,662,790,000 |
|
|
|
137,309,700 |
|
|
|
13,467,940,000 |
|
|
|
3,262,392,000 |
|
|
|
6,752,418,000 |
|
|
|
65,042,940,000 |
|
|
|
96,929,830,000 |
|
|
|
232,397,700,000 |
|
|
|
149,789,700,000 |
|
|
|
63,909,860,000 |
|
|
|
487,334,700,000 |
|
|
|
1,875,023,000 |
|
|
|
333,216,900 |
|
|
|
60,076,090 |
|
|
|
242,179,800,000 |
|
|
|
6,967,273,000 |
|
|
|
21,714,750,000 |
|
|
|
684,831,400 |
|
|
|
1,112,714,000 |
|
|
|
104,993,600,000 |
|
|
|
34,906,950,000 |
|
|
|
29,554,530,000 |
|
|
|
260,317,300 |
|
|
|
165,326,300,000 |
|
|
|
875,817,500,000 |
|
|
|
19,618,080,000 |
|
|
|
357,004,100 |
|
|
|
705,540,000 |
|
|
|
395,776,000 |
|
|
|
18,151,570,000 |
|
|
|
996,704,600 |
|
|
|
1,859,002,000 |
|
|
|
321,401,200,000 |
|
|
|
356,051,900,000 |
|
|
|
21,124,930,000 |
|
|
|
331,067,129,856 |
|
|
|
1,779,256,000 |
|
|
|
11,560,490,000 |
|
|
|
158,703,400,000 |
|
|
Timor-Leste |
506,063,100 |
|
|
|
1,868,426,000 |
|
|
|
186,242,100 |
|
|
|
11,359,840,000 |
|
|
|
26,301,270,000 |
|
|
|
268,741,100,000 |
|
|
|
6,615,419,000 |
|
|
|
6,911,251,000 |
|
|
|
60,296,500,000 |
|
|
|
2,016,393,000,000 |
|
|
|
12,150,930,000,000 |
|
|
|
13,414,320,000 |
|
|
|
11,859,850,000 |
|
|
|
287,493,600 |
|
|
|
104,957,600,000 |
|
|
|
45,081,910,000 |
|
|
|
11,217,680,000 |
|
|
|
4,747,551,000 |
|
Part A<= o:p>
Rights =
and
Obligations of the Association
1. RIGHT TO=
GRANT
LICENCES
=
The
Association may grant licences in respect of the International Release and =
in
respect of any part of the International Release.
2. &=
nbsp; INTEGRITY
OF THE CORE
2.1 The Association shall h=
ave
the sole right to modify the Core or any part of it and to permit any other
person to modify the Core or any part of it.
2.2 The Association shall h=
ave
the sole right to determine the manner of formatting of the Core included
within the International Release.
3. &=
nbsp; NAMESPACE
IDENTIFIERS
The Association shall have the sol=
e right
to issue Namespace Identifiers and to permit any other person to issue
Namespace Identifiers.
4. &=
nbsp; RESERVATION
OF ASSOCIATION’S RIGHTS
Other than as expressly set out in=
this
Part A, nothing in this Schedule 3 in any way limits any of the
Association’s rights, including any right to use, modify, license,
distribute, sell, offer for sale or otherwise exploit any Intellectual Prop=
erty
Right owned by the Association.
Part B
Rights and Obligations of Members
5. MEMBERS&=
#8217;
RIGHTS
5.1 As a Member, each Member
shall have the right, subject to the terms of this Part B, to:
5.1.1 use, and permit the
Member’s officers, employees, agents and contractors to use, the
International Release;
5.1.2 create National Extensi=
ons
and use and modify those National Extensions;
5.1.3 create Derivatives and =
use
and modify those Derivatives;
5.1.4 modify the manner of
formatting of the copy of the Core distributed to the Member as part of the
International Release;
5.1.5 distribute the Member=
8217;s
National Release (including the International Release) to Affiliates;
5.1.6 grant
licences to Affiliates to:
(a) use
the Member’s National Extensions and Derivatives forming part of the
Member’s National Release;
(b) create
Third Party Extensions from the Member’s National Extensions and use =
and
modify those Third Party Extensions;
(c) create
Derivatives from the Member’s National Extensions and Member’s
Derivatives and use and modify any such Derivatives created by that Affilia=
te;
(d) &nb= sp; incorporate the Member’s National Extensions and Derivatives into the Affiliate’s products; and
(e) sub-license the Member’s Nat=
ional
Extensions and Derivatives, and any Derivatives and Third Party Extensions
created by the Affiliate from the Member’s National Extensions and
Member’s Derivatives, to users of the Affiliate’s products;
=
5.1.7 grant licences to other
Members (each such Member being a “Licensee Member”, and=
the
Member granting the licence being the “Licensor Member”)=
to:
(a) use
the Licensor Member’s National Extensions and Derivatives forming par=
t of
the Licensor Member’s National Release;
(b) incorporate
the Licensor Member’s National Extensions into the Licensee
Member’s own National Extensions and use and modify any such National
Extensions created by the Licensee Member;
(c) create
Derivatives from the Licensor Member’s National Extensions and use and
modify those Derivatives; and
(d) sub-license
the Licensor Member’s National Extensions and Derivatives, and any
Derivatives and National Extensions created by the Licensee Member from the
Licensor Member’s National Extensions, to Affiliates; and
5.1.8 distribute the Member=
8217;s
products containing the International Release (or any part of it) to persons
other than Affiliates and other Members, provided that the use by such pers=
ons
of the Member’s products is subject to an end user licence agreement
that:
(a) gives
the licensee only those rights in respect of the International Release as a=
re
strictly necessary for the licensee’s use of the Member’s produ=
cts;
and
(b) includes
terms that the Member reasonably considers necessary or desirable to protect
the Association’s Intellectual Property, including such terms as the
Association may prescribe by Regulations.
5.2 =
A
Member’s rights under paragraph 5.1 are:
5.2.1 non-exclusive; and
5.2.2 non-transferable, excep=
t with
the prior consent of the Association.
5.3 A Member may only use t=
he
International Release, and must ensure that its officers, employees, agents=
and
contractors only use the International Release:
5.3.1 for the Member’s
internal business purposes (including the creation by the Member of National
Extensions and Derivatives and the distribution by the Member of its Nation=
al
Release);
5.3.2 in the development and
operation of the Member’s information systems;
5.3.3 for the Member’s
research purposes; and/or
5.3.4 in the Member’s s=
ystems
(including browsers and data analysis systems) made available to the general
public for accessing and/or retrieving any part of the International Release
and/or the Member’s National Release and/or data encoded using the
foregoing, provided that if those systems are used by persons other than
Affiliates, those users are not able to extract any substantial portion of
SNOMED CT.
5.4 Each Member shall ensur=
e that
its use of the International Release, and the use by its officers, employee=
s,
agents and contractors of the International Release, complies with all
Regulations made by the Association from time to time.
5.5 Each Member shall compl=
y with
the Internet security measures prescribed by the Association by Regulations
from time to time.
5.6 Each Member must distri=
bute
its National Release in such manner that no person may access any part of t=
he
National Release without first entering into a licence agreement with the
Association on the Affiliate Licence Terms, and thereby becoming an
Affiliate. The Association may
prescribe by Regulations the manner in which a Member is required to ensure
that its National Release is only distributed to persons who are Affiliates=
.
5.7 A Member may distribute=
the
Core as part of its National Release in a format that has been modified in
accordance with paragraph 5.1.4, provided that the Member also distributes =
the
Core as part of its National Release in the same format as the Core is dist=
ributed
by the Association as part of the International Release.
5.8 Each licence granted by=
a
Member under paragraph 5.1.6 must comply with the requirements set out in
paragraph 7.
5.9 Subject to paragraph 5.=
1.4,
no Member may:
5.9.1 modify any part of the =
Core
distributed to it as part of the International Release; or
5.9.2 grant or purport to gra=
nt any
right to any person (including any Affiliate) to modify any part of the Core
distributed to it as part of the International Release.
5.10 No Member shall acquire any right, =
title
or interest in or to the International Release or any part of it, other tha=
n as
expressly provided in this Part B.
5.11 Each Member shall have the right to
prescribe reasonable conditions, consistent with the Articles, in relation =
to
the use and/or distribution by Affiliates of the International Release, and
Affiliates’ products containing the International Release (or any par=
t of
it), within the Member’s Territory.&=
nbsp;
Any Member prescribing any such conditions shall promptly publish th=
ose
conditions in a manner reasonably likely to bring them to the attention of
Affiliates, and shall provide a copy of those conditions to the Association=
.
6. DURATION=
OF
RIGHTS
6.1 The rig=
hts of
each Member under paragraph 5.1 shall:
6.1.1 commence upon that Memb=
er
becoming a Member; and
6.1.2 automatically terminate=
upon
that Member ceasing to be a Member, except as expressly provided in paragra=
ph
6.2.
6.2 If a Member ceases to b=
e a
Member, without being replaced in accordance with clause 4.4 of these Artic=
les,
and subject to paragraph 6.3, the Member’s rights under paragraphs 5.=
1.1
to 5.1.8 (except 5.1.2) shall continue following the Member ceasing to be a
Member, but:
6.2.1 the Member’s righ=
ts
under those provisions in respect of the International Release (itself and =
as
part of the Member’s National Release) shall be limited to the most
recent version of the International Release on the date that the Member cea=
sed
to be a Member and the Member shall have no rights in respect of any subseq=
uent
version of the International Release;
6.2.2 the Member’s righ=
ts
under paragraph 5.1.3 shall be limited to non-Standards-Based Derivatives; =
and
6.2.3 while the Member may not
create new National Extensions after the date the Member ceased to be a Mem=
ber
it may continue to use National Extensions created before the date the Memb=
er
ceased to be a Member.
6.3 If a Member ceases to b=
e a
Member, without being replaced in accordance with clause 4.4 of these Artic=
les,
and a new Member is subsequently admitted in the former Member’s
Territory in accordance with clause 4.3 of these Articles, the former
Member’s rights that are continued under paragraph 6.2 shall
automatically terminate.
7. &=
nbsp; LICENCES
GRANTED BY MEMBERS
7.1 Each li=
cence
granted by a Member under paragraph 5.1.6 must:
7.1.1 not conflict with any
provision of the Affiliate Licence Terms;
7.1.2 provide that no rights =
are
granted under it other than to a person who is an Affiliate;
7.1.3 not grant or purport to=
grant
any licence or other right to the Affiliate in respect of the International
Release or any part of it;
7.1.4 not confer or purport to
confer any obligation or liability on the Association;
7.1.5 provide that, upon that
Member being replaced in accordance with clause 4.4 of these Articles, the =
outgoing
Member’s rights and obligations under the licence shall automatically
transfer to the replacement Member;
7.1.6 survive the Member ceas=
ing to
be a Member in accordance with clauses 4.5.3 or 4.5.5 of these Articles, and
not be terminable by the Member except in the same circumstances as the
Association may terminate a licence with an Affiliate under the Affiliate
Licence Terms;
7.1.7 provide that the Affili=
ate
may not create any Standards-Based Third Party Extension or any Standards-B=
ased
Derivative from the Member’s National Extensions unless that Affiliate
has been issued with a Namespace Identifier in accordance with paragraph
9;
7.1.8 require the Affiliate to
ensure that all Standards-Based Third Party Extensions and Standards-Based
Derivatives that the Affiliate creates from the Member’s National
Extensions are created and maintained in accordance with, and comply with, =
all
applicable Standards;
7.1.9 provi=
de
that either:
(a) the
Member shall own all Intellectual Property Rights in all Standards-Based Th=
ird
Party Extensions that the Affiliate creates from the Member’s National
Extensions; or
(b) the Affiliate shall own all Intellectual Property Rights in all
Standards-Based Third Party Extensions that the Affiliate creates from the
Member’s National Extensions, but that the Affiliate may not assign or
otherwise transfer those Intellectual Property Rights to any other person
unless (i) that person is an Affiliate and has a Namespace Identifier; and =
(ii)
the transfer is notified in writing to both the Member and the Association
within thirty (30) days after the transfer;
&nb=
sp; 7.1.10 provide that either:
(a) if
agreed between the Member and the Affiliate, the Member shall own all
Intellectual Property Rights in all Standards-Based Derivatives that the Af=
filiate
creates from the Member’s National Extensions and Derivatives; or
(b) the Affiliate shall own all Intellectual Property Rights in all
Standards-Based Third Party Derivatives that the Affiliate creates from the
Member’s National Extensions, but that the Affiliate may not assign or
otherwise transfer those Intellectual Property Rights to any other person
unless (i) that person is an Affiliate and has a Namespace Identifier; and =
(ii)
the transfer is notified in writing to both the Member and the Association
within thirty (30) days after the transfer;
&nb=
sp; 7.1.11 provide that:
(a) if
requested by the Member, the Affiliate shall transfer to the Member, or to =
such
other person as the Member may nominate (including the Association), all of=
its
Intellectual Property Rights in such Standards-Based Third Party Extensions=
(or
parts thereof) created by the Affiliate from the Member’s National
Extensions as the Member may specify;
(b) if
requested by the Member and agreed by the Affiliate in the Affiliate’s
sole discretion, the Affiliate shall transfer to the Member, or to such oth=
er
person as the Member may nominate (including the Association), all of its
Intellectual Property Rights in such Standards-Based Derivatives created by=
the
Affiliate from the Member’s National Extensions as the Member may
specify; and
(c) upon
the transfer to the Member of the Intellectual Property Rights in any Third
Party Extension (or part thereof) or Derivative in accordance with
sub-paragraph (a) or (b) of this paragraph 7.1.11:
(i) responsibil=
ity
for the maintenance and distribution of that Third Party Extension (or part
thereof) or Derivative shall also transfer from the Affiliate to the Member=
or
other transferee nominated by the Association (as the case may be); and
(ii) accordingly, in t=
he
case of a Third Party Extension, that SNOMED CT Content shall cease to be a
Third Party Extension and shall become part of the Member’s National
Extensions (if transferred to the Member) or the Core (if transferred to the
Association).
7.2 Any licence granted or
purported to be granted under paragraph 5.1.6 that does not comply with the
requirements set out in paragraph 7.1 shall be void but the Association may=
, by
Resolution of the Management Board, give retrospective permission to the Me=
mber
to grant that licence, in which case that licence shall not be void by virt=
ue
of this paragraph 7.2.
7.3 A licence granted by a =
Member
under paragraph 5.1.6 may: (i) limit the Affiliate’s rights to the
Member’s Territory; (ii) limit the Affiliate’s rights to the
Member’s Territory together with the Territories of other Members from
time to time; or (iii) not be subject to any territorial limitation. A Member shall notify the Associat=
ion as
soon as reasonably practicable, and in any event within thirty (30) days, a=
fter
granting any licence as described in sub-paragraphs (ii) or (iii) of this
paragraph 7.3, and the Association shall publish the details of that licenc=
e to
other Members.
7.4 Any licence fees and ot=
her
amounts charged by a Member under licences granted under clause 5.1.6 or cl=
ause
5.1.8 shall be calculated and set by the Member at no greater a level than =
the
Member estimates, in good faith, will allow it to recover its costs incurre=
d in
connection with its membership of the Association and activities performed
pursuant to that membership. =
7.5 Each Me=
mber
shall comply with such Regulations as the Association may prescribe from ti=
me
to time for the purpose of:
7.5.1 ascertaining a Member=
8217;s
compliance with paragraph 7.4; and
7.5.2 determining the action =
that a
Member is required to take if it earns licence fees or other amounts in exc=
ess
of the level specified in paragraph 7.4 (which may include, without limitat=
ion:
(i) the Member reducing its licence fees or other amounts for future period=
s;
(ii) the Member reimbursing some or all of the excess licence fees or other
amounts to some or all Affiliates or other persons; and (iii) the Member
accounting to the Association for some or all of the excess licence fees or
other amounts).
8. &=
nbsp; NATIONAL
EXTENSIONS AND DERIVATIVES
8.1 Each Member shall ensur=
e that
all Standards-Based National Extensions and Standards-Based Derivatives tha=
t it
creates are created and maintained in accordance with, and comply with, all
applicable Standards including the Association’s quality assurance
processes.
8.2 Subject to paragraphs 8=
.3,
8.4, 8.9 and 8.10, each Member shall own all Intellectual Property Rights in
all National Extensions and Derivatives that it creates.
8.3 A Member shall, if requ=
ested
by the Association, transfer to the Association all of its Intellectual
Property Rights in such Standards-Based National Extensions (or parts there=
of)
as the Association may specify.
8.4 A Member shall, if requ=
ested
by the Association and agreed by the Member in the Member’s sole disc=
retion,
transfer to the Association all of its Intellectual Property Rights in such
Standards-Based Derivatives created from the Core as the Association may
specify.
8.5 Upon the transfer to the
Association of the Intellectual Property Rights in any National Extension (=
or
part thereof) or Derivative in accordance with paragraph 8.3 or 8.4:
8.5.1 responsibility for the
maintenance and distribution of that National Extension (or part thereof) or
Derivative shall also transfer from the Member to the Association;
8.5.2 accordingly, in the cas=
e of a
National Extension, that SNOMED CT Content shall cease to be a National
Extension and shall become part of the Core; and
8.5.3 Until that National Ext=
ension
(or part thereof) or Derivative becomes part of the International Release t=
he
Member shall have the same rights and obligations in relation to that Natio=
nal
Extension (or part thereof) or Derivative that the Member has in relation to
the International Release.
8.6 A Member
shall, if requested by the Association:
8.6.1 require an Affiliate (in
accordance with sub-paragraph (a) of paragraph 7.1.11) to transfer to the
Member, or to such other person as the Association may nominate (including =
the
Association itself), the Affiliate’s Intellectual Property Rights in =
such
Standards-Based Third Party Extensions (or parts thereof) created by the
Affiliate from the Member’s National Extensions as the Association may
specify to the Member; and
8.6.2 seek an Affiliate’=
;s
consent (in accordance with sub-paragraph (b) of paragraph 7.1.11) to trans=
fer
to the Member, or to such other person as the Association may nominate
(including the Association itself), the Affiliate’s Intellectual Prop=
erty
Rights in such Standards-Based Derivatives created by the Affiliate from th=
e Member’s
National Extensions as the Association may specify to the Member.
8.7 The Association shall
reimburse a Member for all costs and expenses incurred by the Member in
obtaining an Affiliate’s consent in accordance with paragraph 8.6.2
(including any sums paid to the Affiliate in consideration for the transfer=
of
its Intellectual Property Rights in accordance with that paragraph), provid=
ed
that the Member obtains the Association’s prior approval before incur=
ring
any such costs or expenses.
8.8 A Member shall, if requ=
ested
by the Association or another Member, provide the Association or other Memb=
er
(as the case may be) with full details of the specification for the process
that the Member has used to create any Derivative that is not a Standards-B=
ased
Derivative.
8.9 A Member shall, if requ=
ested
by the Association or another Member, provide the Association or other Memb=
er
(as the case may be) with sufficient information, co-operation and assistan=
ce
in relation to any of the Member’s National Extensions and Derivative=
s to
enable the Association or other Member (as the case may be) to make an
assessment about whether the Intellectual Property Rights in those National
Extensions or Derivatives should be transferred to the Association in
accordance with paragraphs 8.3 and 8.4.
8.10 If a Member is replaced in accordan=
ce
with clause 4.4 of these Articles, all Intellectual Property Rights in the
former Member’s National Extensions and the former Member’s
Derivatives shall automatically transfer to the replacement Member.
8.11 If a Member ceases to be a Member otherwise than as described in paragraph 8.10, all Intellectual Property Ri= ghts in the former Member’s National Extensions and the former Member̵= 7;s Derivatives shall transfer to such person as the national government of the former Member’s Territory may nominate (unless the national government waives such transfer) or, in default of such nomination or waiver, to such person as the Association may nominate (including the Association itself).<= o:p>
9. &=
nbsp; NAMESPACES
9.1 Only the Association may
issue Namespace Identifiers.
9.2 The Association shall, =
upon
written request from a Member or an Affiliate in accordance with such
procedures as the Association may prescribe by Regulations, issue one or mo=
re
Namespace Identifiers to the Member or Affiliate. The Association shall not unreason=
ably
refuse to issue a Namespace Identifier to a Member or an Affiliate.
9.3 The Association shall be
responsible for ensuring that each Namespace Identifier is only issued to a
single Member or Affiliate.
10. =
THE
ASSOCIATION’S TRADE MARKS
10.1 No
Member shall:
10.1.1 use any trade mark or service mark =
(or
any registrations thereof), other than the Association’s trademarks, =
in
any name that includes the word “SNOMED”, or that is confusingly
similar to SNOMED,
10.1.2 apply for any trade mark or service=
mark
(or any registrations thereof) in any name that includes the word
“SNOMED”, or that is confusingly similar to SNOMED,
10.1.3 abbreviate the marks SNOMED or
=
10.1.4 do anything with respect to the for=
egoing
trade marks that damages or could reasonably be deemed to reflect adversely=
on
the Association or such trade marks.
10.2 Each Member shall:=
10.2.1 include the following notice on all=
media
on which its National Release (or any part of it) is distributed and on the
documentary form of each licence granted by the Member under paragraph 5.1.=
6:
“This material includes SNOM=
ED
Clinical Terms® (SNOMED CT®) which is used by permission of the
International Health Terminology Standards Development Organisation
(IHTSDO). All rights reserved=
. SNOMED CT®, was originally cre=
ated
by The College of American Pathologists.&n=
bsp;
“SNOMED” and “
10.2.2 specify in all media on which the
National Release are distributed the version and date of the International
Release contained in the National Release.
10.3 The Association will set out in
regulations the terms on which members can use the “SNOMED” and
“SNOMED CT” trademarks and all use by a Member of the
“SNOMED” and “SNOMED CT” trademarks, and all goodwi=
ll
resulting from that use, shall inure to the Association’s benefit.
11. =
REPRESENTATIONS,
WARRANTIES AND LIMITATIONS OF LIABILITY
11.1 To the extent permitted by law, the
Association excludes all representations, warranties and conditions that wo=
uld
otherwise be implied by law in this Part B (including, without limitation, =
all
implied warranties of merchantability or fitness for a particular
purpose).
11.2 Without limiting paragraph 11.1, the
Association does not represent or warrant that the International Release or=
any
part of it will satisfy any Member’s requirements, operate in
combinations selected by the Member or be free from defects or errors.
11.3 The Association shall not be liable=
to
any Member, and no Member shall be liable to the Association, whether in
contract, tort (including negligence), misrepresentation, breach of statuto=
ry
duty or otherwise, for any of the following arising under or in connection =
with
this Part B (including, without limitation, in respect of the Member’s
use of or inability to use the International Release or any part of it):
11.3.1 indirect or consequential loss;
11.3.2 special or punitive damages;
11.3.3 loss of profits, loss of savings an=
d loss
of revenue;
11.3.4 loss of business, loss of reputatio=
n and
loss of goodwill; and
11.3.5 loss of data.
11.4 The entire aggregate liability of t=
he
Association to each Member, and of each Member to the Association, arising
under or in connection with this Part B in any financial year, whether in
contract, tort (including negligence), misrepresentation, breach of statuto=
ry
duty or otherwise, shall not in any event exceed the Annual Fee paid or pay=
able
by that Member in respect of that financial year.
11.5 Nothing in this Part B excludes or =
limits
the liability of the Association or any Member for fraud (including fraudul=
ent
misrepresentation) or for any other liability that by law cannot validly be
excluded or limited (but only to the extent that the liability cannot valid=
ly
be excluded or limited).
11.6 A Member may not bring any claim ag=
ainst
the Association, and the Association may not bring any claim against any
Member, arising under or in connection with this Part B (including, without
limitation, in respect of the Member’s use of or inability to use the
International Release or any part of it) more than two years after the date=
on
which the cause of action arose.
Part C
Defined Terms and Interpretation
12. =
DEFINITIONS
=
In
this Schedule 3, the following terms have the following meanings:
“Affiliate Licence Terms<=
/b>”
means the terms set out in Exhibit 1 to this Schedule 3 (including the
Appendices to that Exhibit), as may be amended from time to time;
“Core” means th=
e SNOMED
CT Content that is controlled, maintained and distributed by the Association
from time to time;
“Cross-Map” mea=
ns a
work consisting of (i) SNOMED CT Content and (ii) content of another
nomenclature, classification or knowledge structure, together with a set of
relationships between (i) and (ii);
“Derivative” me=
ans a
work consisting of (a) SNOMED CT Content, from the Core or an Extension
together with (b) either (i) additional properties an/or information about =
such
SNOMED CT content and/or (ii) any set of relationships between that SNOMED =
CT
Content and content of other nomenclature, classification or knowledge
structure, and includes a Cross-Map and a Sub-Set;
“Extension” mea=
ns a
work consisting of SNOMED CT Content alone that is supplementary to other
SNOMED CT Content and that depends on that other SNOMED CT Content, and
includes a translation of any SNOMED CT Content into any language other than
the original language of its development;&=
nbsp;
“International Release”
means the release produced and distributed by or on behalf of the Associati=
on,
consisting of the Core, the Specifications, the Association’s Derivat=
ives
and other documents and software;
“Namespace Identifier=
”
means a code or that part of a code that identifies the organisation
responsible for creating and maintaining a Standards-Based Extension or a
Standards-Based Derivative and is used as an element of SNOMED CT Identifie=
rs;
“National Extension=
8221; means
an Extension that is controlled and maintained by a Member and is SNOMED CT
Content supplementary to the Core;
“National ReleaseR=
21;
means, in respect of each Member, the release produced and distributed by t=
he
Member, consisting of the International Release, the Member’s National
Extensions, the Member’s Derivatives and other documents and
software;
“Relationship” =
means a
relationship, of a kind defined by the Association in Specifications, betwe=
en
concepts (which may be, without limitation, a hierarchical or an associative
relationship) or between a concept and a description;
“
“
"
“Specification”=
means
specifications promulgated by the Association from time to time for products
and processing relating to SNOMED CT, including specifications of the inter=
nal
logic of SNOMED CT, editorial policies, guidelines and characteristics;
“Standard” mean=
s a
Specification that is formally adopted by the Association through such
procedures as the Association may prescribe by Regulations;
“Standards – Based<=
/b>”
means, in respect of an Extension (including a National Extension and a Thi=
rd
Party Extension) or a Derivative, an Extension or Derivative the creation of
which is the subject of one or more Standards;
“Sub-Set” means=
a
sub-set of SNOMED CT Content that is grouped together for one or more purpo=
ses;
and
“Third Party Extension”
means an Extension that is controlled and maintained by an Affiliate and is
SNOMED CT Content supplementary to the Core or a National Extension (or bot=
h).
13. =
INTERPRETATION
13.1 In this Schedule 3, unless the cont=
ext
requires otherwise, a reference to a paragraph is to a paragraph of this
Schedule 3.
13.2 A reference in this Schedule 3 to t=
he
“modification” (or any similar term) of any SNOMED CT
Content includes the alteration and deletion (or both) of that SNOMED CT
Content or any part of it.
13.3 In this Schedule 3, a reference to a
Third Party Extension being created from a National Extension means that the
SNOMED CT Content in that Third Party Extension is supplementary to and
dependent on the National Extension (and such a Third Party Extension is no=
t to
be treated as being created from the Core notwithstanding that it may also =
be
supplementary to and dependent on the Core).
Exhibit
1
Affiliate
Licence Terms
SNOMED
CT® AFFILIATE LICENCE AGREEMENT
|
IMPORTANT NOTICE – PLEASE READ THE FOLLOWING CAREFULLY Thi=
s is a
Licence Agreement between (1) The International Health Terminology
Standards Development Organisation (forening med begrænset ansv=
ar),
an association (foreningen) established under the laws of Denmark, whose
principal place of business is at [ ], Copenhagen, Denmark=
(the
“Licensor”) and (2) the person or organisation to which
the International Release of SNOMED CT (whether on its own or as part of a
Member’s National Release of SNOMED CT) is distributed or otherwise
made available (the “Licensee”). By
downloading, accessing or using any part of the International Release of
SNOMED CT or a Member’s National Release of SNOMED CT, or exercising
any rights granted under this Licence Agreement, the Licensee agrees to be
bound by the terms of this Licence Agreement. |
1. &=
nbsp; DEFINED
TERMS
=
In
this Licence Agreement, terms defined in Appendix A (Defined Terms) =
have
the meanings set out in that Appendix.
2. &=
nbsp; GRANT
OF LICENCE
2.1 The Licensor grants the
Licensee, subject to the terms of this Licence Agreement, a perpetual (subj=
ect
to revocation in accordance with clause 5), worldwide, non-exclusive,
non-transferable licence for the term of this Licence Agreement to:
2.1.1 use, and permit the
Licensee’s officers, employees, agents and contractors to use, the
International Release;
2.1.2 create Extensions and
Derivatives from the International Release and use and modify those Extensi=
ons
and Derivatives;
2.1.3 incorporate the Interna=
tional
Release into Licensee Products, use and modify the International Release in
those Licensee Products only, and distribute Licensee Products under a
sub-licence in accordance with clause 2.1.5;
2.1.4 modify the manner of
formatting of the copy of the SNOMED CT Core distributed to the Licensee as
part of the International Release or as part of a Member’s National
Release; and
2.1.5 subject to clause 5.=
8,
grant sub-licenses of the International Release to End Users to the extent
necessary for the End Users to use the Licensee Products.
2.2 The Licensee may only u=
se the
International Release, and must ensure that its officers, employees, agents=
and
contractors only use the International Release:
2.2.1 for the Licensee’s
internal business purposes (including the creation by the Licensee of Exten=
sions,
Derivatives and other Licensee Products along with the licensing and
distribution by the Licensee of the Licensee Products);
2.2.2 in the development and
operation of the Licensee’s information systems;
2.2.3 for the Licensee’s
research purposes; and/or
2.2.4 in the Licensee’s
systems (including browsers and data analysis systems) made available to the
general public for accessing and/or retrieving any part of the International
Release and/or data encoded using the foregoing, provided that users of tho=
se
systems are not able to extract any substantial portion of SNOMED CT and
provided further that no fee is charged for access to those systems except
where access is incidental to the provision of training or consulting servi=
ces.
2.3 The
Licensee is only permitted under this Licence Agreement to create Extensions
from the International Release and to create Derivatives from the Internati=
onal
Release and from those Extensions. The Licensee may only create an Extensio=
n or
a Derivative from any Member’s Extension pursuant to a licence agreem=
ent
with that Member in respect of the Member’s National Release.=
2.4 The Licensee is not per=
mitted
to translate any part of the International Release into any other human
language without the prior written consent of the Licensor.
2.5 Each
sub-licence granted by the Licensee under clause 2.1.5 must:
2.5.1 not grant the End User =
any
greater rights in respect of the International Release than the Licensee it=
self
has under this Licence Agreement;
2.5.2 not permit the End User=
to do
any act or thing in respect of the International Release that the Licensee =
is
prohibited from doing under this Licence Agreement;
2.5.3 not permit the End User=
to
sub-license or transfer any of its rights under the sub-licence (unless the=
End
User is also an Affiliate, in which case that Affiliate shall be entitled to
sub-license further its rights under the sub-licence with the Licensee, sub=
ject
to the same restrictions as apply to sub-licensing the International Release
under the Affiliate’s licence agreement with the Licensor);
2.5.4 terminate automatically=
upon
termination of this Licence Agreement;
2.5.5 provide that the End Us=
er may
apply directly to the Licensor upon receiving notice that the sub-licence w=
ill
terminate in accordance with clause 2.5.4, and that the Licensor may=
in
such circumstances (but shall not be obliged to):
(a) grant
the End User a licence in respect of the International Release for a limited
period in order to enable the End User to continue to use the Licensee Prod=
ucts
that are subject to the sub-licence during that period; or
(b) give
the End User an assurance or undertaking that for a limited period the Lice=
nsor
will not seek to prevent the End User from using the Licensee Products; and=
=
2.5.6 permit the Licensee to
disclose the terms of the sub-licence to the Licensor in accordance with clause
8.
2.6 If the Licensee becomes=
aware
of any material error or change or correction needed in the International
Release, the Licensee agrees to advise the Licensor promptly of such error,
change or correction by following the Licensor’s procedures for change
notification that the Licensor prescribes by Regulations and notifies to the
Licensee from time to time.
2.7 The Licensee shall comp=
ly
with the Internet security measures that the Licensor prescribes by Regulat=
ions
and notifies to the Licensee from time to time.
3. &=
nbsp; EXTENSIONS
AND DERIVATIVES
3.1 The Licensee may not cr=
eate
any Standards-Based Extension or any Standards Based Derivative unless it h=
as
first been issued with a Namespace Identifier by or on behalf of the Licens=
or.
3.2 The Licensee may reques=
t that
the Licensor issue it with a Namespace Identifier, and the Licensor shall n=
ot
unreasonably refuse to do so taking into account amongst other things quali=
ty
assurance, governance processes, Standards and Regulations.
3.3 The Licensee shall ensu=
re
that all Standards-Based Extensions and Standards Based Derivatives that the
Licensee creates under this Licence Agreement are created in accordance wit=
h,
and comply with, all applicable Standards (including, without limitation, a=
s to
the use of Namespace Identifiers).
3.4 Subject
to clauses 3.5 and 3.6, the Licensee shall own all
Intellectual Property Rights in all Extensions and Derivatives that the
Licensee creates under this Licence Agreement. The Licensee may not assign =
or
otherwise transfer those Intellectual Property Rights to any other person
unless (i) that person is an Affiliate and, in the case of Standards-Based
Extensions or Standards-Based Derivatives, has a Namespace Identifier; and =
(ii)
the transfer is notified in writing to the Licensor within thirty (30) days
after the transfer.
3.5 The Licensee shall, if
requested by the Licensor, transfer to the Licensor or a Member nominated by
the Licensor all of its Intellectual Property Rights in such Standards-Based
Extensions (or parts thereof) as the Licensor may specify.
3.6 The Licensee shall, if
requested by the Licensor and agreed by the Licensee in the Licensee’s
sole discretion, transfer to the Licensor or a Member nominated by the Lice=
nsor
all of its Intellectual Property Rights in such Standards-Based Derivatives=
as
the Licensor may specify.
3.7 Upon the transfer to the
Licensor, or to a Member, of the Intellectual Property Rights in any
Standards-Based Extension (or part thereof) or Standards-Based Derivative in
accordance with clauses 3.5 or 3.6:
3.7.1 responsibility for the
maintenance and distribution of that Extension (or part thereof) or Derivat=
ive
shall also transfer from the Licensee to the Licensor or the Member (as the
case may be); and
3.7.2 the
Licensor hereby grants a licence back to the Licensee from the Licensor or =
will
procure from the Member a licence back to the Licensee (as the case may be)=
of
that Extension (or part thereof) or Derivative, on the same terms as apply =
to
the International Release under cl=
ause 2
of this Licence Agreement, until that Extension (or part thereof) or Deriva=
tive
becomes part of the International Release or the Member’s National
Release (as the case may be).
4. &=
nbsp; MODIFICATIONS
TO THE INTERNATIONAL RELEASE
4.1 Subject to clause 2.=
1.4,
the Licensee may not modify any part of the SNOMED CT Core distributed as p=
art
of the International Release or as part of a Member’s National Releas=
e.
4.2 Subject to any express =
and
specific statement to the contrary in the documentation distributed as part=
of
the International Release, the Licensee may not modify any of the documenta=
tion
(including Specifications) or software (unless provided in source code form)
distributed as part of the International Release.
4.3 The Licensee may, by wr=
itten
notice, request the Licensor to modify the SNOMED CT Core. Upon receipt of such written notic=
e, the
Licensor shall consult with the Licensee and shall give due consideration a=
s to
whether the proposed modification should be made based on the Licensor’s edit=
orial
guidelines and policies. Following due consideration of the matter, includi=
ng
consideration of any information presented by the Licensee, the Licensor sh=
all
inform the Licensee whether the proposed modification shall be made and if =
the
Licensor agrees that the proposed modification should be made, the Licensor
shall give a non-binding indication of when, reasonably and in good faith, =
it
anticipates that the proposed modification will be made. If the Licensee would like the con=
tent
of the proposed modification to be developed more quickly than the Licensor=
has
indicated, the Licensee may itself undertake or procure the undertaking of =
the
development of the content of the proposed modification (outside of any
existing Licensor’s support services contract). On receipt of the developed conten=
t of
the proposed modification, the Licensor will then give due consideration as=
to
whether the developed content meets the Licensor’s quality assurance,
other governance processes, Standards and Regulations. If the developed con=
tent
meets the Licensor’s quality assurance, other governance processes,
Standards and Regulations then the Licensor shall incorporate the modificat=
ion
into the SNOMED CT Core according to its schedule which will give due
consideration as to when the proposed modification shall be incorporated in=
to
the SNOMED CT Core, taking into account other proposals for the modificatio=
n of
the SNOMED CT Core and the work required to include the proposed modificati=
on
in the SNOMED CT Core.
5. &=
nbsp; TERM
AND TERMINATION
5.1 This Licence Agreement =
shall
commence on the date on which it comes into effect in accordance with the
notice at the beginning of this Licence Agreement, and shall continue until
terminated in accordance with this clause 5.
5.2 Either party may termin=
ate
this Licence Agreement if the other party commits a material breach of any =
of
its obligations under this Licence Agreement in accordance with the followi=
ng
procedure:
5.2.1 the party seeking to
terminate the License Agreement (the “Terminating Party”)
shall serve an escalation notice (the “Escalation Notice”=
;)
on the other party (the “Defaulting Party”) requiring the
Defaulting Party to nominate a member of its senior management team to meet=
with
a member of the Terminating Party’s senior management team to seek to
resolve in good faith the matter giving rise to the service of the escalati=
on
notice;
5.2.2 The representatives of =
the
parties identified in accordance with clause 5.2.1 shall meet in good faith=
to
seek to resolve the matter. I=
f they
are unable to resolve the matter within 45 days of the date of the Escalati=
on
Notice the Terminating Party may serve a formal breach notice (the “<=
b>Breach
Notice”) on the Defaulting Party requiring it to remedy the breach
within 90 days.
5.2.3 If the Defaulting Party=
does
not remedy the breach within 90 days of the date of the Breach Notice the
Terminating Party may terminate the License Agreement by giving 180 days
written notice to the Defaulting Party (the “Termination Notice”).
5.3 The Licensor may not
terminate this Licence Agreement except in accordance with clause 5.2.
5.4 The Licensee may termin=
ate
this Licence Agreement by giving up to twelve (12) months’ prior writ=
ten
notice to the Licensor at any time between the Licensor giving notice of a
variation under clause 6.3 and that variation becoming effective in
accordance with clause 6.3.
5.5 Upon termination of this
Licence Agreement in accordance with this clause 5, all licences gra=
nted
under this Licence Agreement shall automatically and immediately be revoked=
.
5.6 The
Licensee shall, by no later than forty five (45) days after termination of =
this
Licence Agreement for any reason, remove all copies of the International
Release from its computer systems and destroy all copies of electronic, pap=
er
copy and other media containing or representing any part of the Internation=
al
Release. The Licensee shall, =
if
requested by the Licensor, certify in writing to the Licensor that the Lice=
nsee
has complied with its obligations under this clause 5.6.
5.7 The Licensee shall, as =
soon
as reasonably practicable following either party giving a Termination Notice
for any reason, and in any event by no later than ninety (90) days after su=
ch
Termination Notice is given, give written notice of such termination to each
End User that the Licensee reasonably believes to be a current user of a
Licensee Product and to each Member in each Member Territory in which the
Licensee has distributed or licensed any Licensee Product.
5.8 The Licensee may not gr=
ant
any new sub-licence under clause 2.1.5 after either party has given
notice under clauses 5.2 or 5.4.
5.9 The Licensor shall be
entitled to publicise the termination of this Licence Agreement to such per=
sons
(including Members, other Affiliates of the Licensor and End Users) and in =
such
manner as it sees fit.
5.10 Clauses 5.6, 5.7, 5.8, 5.9, 7, 8=
and 10 to 14 inclusive shall survive termination of this Lice=
nce
Agreement.
6. &=
nbsp; NEW
VERSIONS AND CHANGES TO LICENCE TERMS
6.1 The Licensor shall noti=
fy the
Licensee when each new version of the International Release is made availab=
le
and there shall be a mechanism for Licensees to access or obtain copies of =
the
new version of the International Release.&=
nbsp;
The Licensee shall be liable for any reasonable distribution charge,=
if
applicable, established by the Licensor for each copy of the new version of=
the
International Release.
6.2 Within one-hundred and =
eighty
(180) days after the Licensor has notified the Licensee of the release of a=
new
version of the International Release, the Licensee must upgrade the version=
of
the International Release in its own systems and in the Licensee Products to
that new version (or alternatively, if a subsequent version of the
International Release is or has been released during the 180-day period, to
that subsequent version at the Licensee’s option).
6.3 The Licensor may vary t=
he
terms of this Licence Agreement by giving written notice to the Licensee. Any such variation shall take effe=
ct not
less than ninety (90) days after the notice is given, as specified in the
notice. If the Licensee does =
not
wish this Licence Agreement to continue subject to the variation, the Licen=
see
may terminate this Licence Agreement in accordance with clause 5.4, =
and
if the Licensee does so then the variation shall not take effect.
6.4 The College of American
Pathologists, as originator of Intellectual Property Rights in the
International Release, shall as a licensee have a specific exception to the
Licensor’s rights in Clause 6.3 in specific circumstances and for a
specific fixed term period to be agreed with the Licensor, and the terms of
such special exemption shall be deemed part of such licensee’s Affili=
ate
Licence Terms. The Licensor w=
ill
publish the terms of the special exemption with the Articles.
7. &=
nbsp; LICENCE
FEES
7.1 The Licensee shall pay =
the
Licence Fees to the Licensor in respect of the Licensee’s activities =
in
7.2 All Licence Fees and ot=
her
amounts payable to the Licensor under this Agreement are exclusive of value
added tax and any other tax of a similar nature, which shall be payable by =
the
Licensee at the prevailing rate in addition to those amounts.
7.3 The Licensee shall, by =
no
later than fourteen (14) days after 1st January and 1st July in each calend=
ar
year, submit a statement of account to the Licensor in such manner and form=
as
the Licensor may prescribe, setting out the Licensee’s activities in
Non-Member Territories in the preceding six-month period, and the
Licensee’s calculation of the Licence Fees and other amounts payable =
to
the Licensor in respect of that period.&nb=
sp;
If the Licence Fees for any period are less than $1,000 (one thousan=
d
7.4 The Licensee shall prov=
ide
the Licensor with such information as the Licensor may reasonably request f=
or
the purpose of verifying any statement of account submitted to the Licensor
under clause 7.3.
7.5 The Licensor shall, fol=
lowing
receipt of a statement of account from the Licensee under clause 7.3,
submit an invoice to the Licensee setting out the Licence Fees and other
amounts payable by the Licensee in respect of the period to which the state=
ment
of account relates. The Licen=
see
shall pay to the Licensor all amounts set out on each invoice submitted und=
er
this clause 7.5 within thirty (30) days of receipt of that invoice.<=
span
style=3D'mso-spacerun:yes'> The Licensee shall make payment un=
der
this clause 7.5 by wire transfer or by such other means as the Licen=
sor
may make available to the Licensee for time to time.
7.6 Interest shall accrue o=
n any
outstanding Licence Fees and other amounts at the rate of the lesser of (a)=
500
basis points above the European Inter-Bank Offer Rate (EURIBOR), calculated
daily from the date on which payment was due and compounding at the end of =
each
calendar month or (b) the maximum amount allowed under applicable law.
8. &=
nbsp; PROTECTION
OF THE LICENSOR’S INTELLECTUAL PROPERTY
8.1 Nothing in this Licence=
Agreement
transfers to the Licensee any right, title or interest in or to the
Intellectual Property Rights in the International Release or any part of it,
except as expressly set out in clause 2.
8.2 The Lic=
ensee
shall not:
8.2.1 use any trademark or se=
rvice
mark (or any registrations thereof) other than the Association’s
trademarks, in any name that includes the word “SNOMED” or that=
is
confusingly similar to
8.2.2 apply for any trade mar=
k or
service mark (or any registrations thereof) in any name that includes the w=
ord
“SNOMED”, or that is confusingly similar to SNOMED,
8.2.3 abbreviate the marks SN=
OMED
or
8.2.4 do anything with respec=
t to
the foregoing trade marks that damages or could reasonably be deemed to ref=
lect
adversely on the Licensor or such trade marks.
8.3 =
The
Licensee shall:
8.3.1 include the following n=
otice
on all media on which the Licensee Products are distributed and on the
documentary form of each sub-licence granted by the Licensee under clause
2.1.5:
&=
nbsp; &nbs=
p; “This
material includes SNOMED Clinical Terms® (SNOMED CT®) which is used=
by
permission of the International Health Terminology Standards Development
Organisation (IHTSDO). All ri=
ghts
reserved. SNOMED CT®, was
originally created by The College of American Pathologists. “SNOMED” and “
=
8.3.2 specify in all media on=
which
the Licensee Products are distributed the version and date of the Internati=
onal
Release contained in the Licensee Product.
8.4 The Licensee shall be
entitled to use the “SNOMED” and “
8.5 The Licensee shall main=
tain
quality standards with respect to modifying, supplementing, marketing and
distributing the Licensee Products, and any services relating thereto, that=
are
in accordance with applicable law and are at least as stringent as the
Regulations developed by the Licensor and published by the Licensor from ti=
me
to time.
8.6 Upon reasonable written
notice from the Licensor, the Licensee shall provide the Licensor with
representative samples of materials, software products, advertising, agreem=
ents
for use of the Licensee Products (other than the terms of those agreements =
that
are unrelated to the Licensor’s rights and obligations under this Lic=
ense
Agreement) and/or other written materials relating to the Licensee’s =
use
of the International Release and the Licensor’s trade marks to enable=
the
Licensor reasonably to ascertain the Licensee’s compliance with its
obligations under this Licence Agreement.&=
nbsp;
In the absence of circumstances giving the Licensor reasonable groun=
ds
to suspect a breach of this Licence Agreement, the Licensor may not give no=
tice
under this clause 8.6 more frequently than once per year.
8.7 If any use of the
International Release (including without limitation use through a Licensee
Product) is reasonably determined by the Licensor to be below the standards=
of
quality required under this Licence Agreement, the Licensor shall notify the
Licensee of such deficiency in writing.&nb=
sp;
Upon receipt of such notice, the Licensee shall take all necessary s=
teps
to correct such deficiency (including such steps as the Licensor may reason=
ably
specify).
8.8 The Licensee shall main=
tain a
complete, accurate and up-to-date register of all sub-licences granted by t=
he
Licensee under clause 2.1.5, and shall make that register available =
for
inspection during normal business hours by the Licensor and its representat=
ives
upon the Licensor giving not less than fourteen (14) days’ prior writ=
ten
notice. The register maintain=
ed by
the Licensee under this clause 8.8 shall at a minimum contain the
following information in respect of each sub-licence: the name and register=
ed
office of the sub-licensee; the Licensee Product subject to the sub-licence;
and the version of the International Release included in that Licensee
Product. In the absence of
circumstances giving the Licensor reasonable grounds to suspect a breach of
this Licence Agreement, the Licensor may not give notice under this clau=
se
8.8 more frequently than once per year.
9. &=
nbsp; COMPLIANCE
WITH LOCAL REQUIREMENTS IN
9.1 The Licensee may only
exercise its rights under this Licence Agreement in a
9.2 Conditi=
ons prescribed
by a Member under clause 9.1 may:
9.2.1 include, without limita=
tion,
a requirement that the Licensee notify the Member before exercising its rig=
hts
under this Licence Agreement in that Member’s territory and a require=
ment
that the Licensee enter into a licence agreement with the Member in respect=
of
that Member’s National Release; and
9.2.2 relate to the Internati=
onal
Release, the Member’s National Release or any part of either of them.=
10. =
AFFILIATE
STATUS
10.1 During the term of this Licence Agr=
eement
the Licensee shall be an Affiliate.
10.2 As an Affiliate, the Licensee shall=
be
entitled to participate in the Licensor’s Affiliates Forum, which is a
forum in which the Licensee and other Affiliates may communicate with the
Licensor and with each other. The Licensor may make Regulations from time to
time governing the Licensee’s participation in the Affiliates Forum. =
New Regulations
that the Licensor shall make from time to time governing participation in t=
he
Affiliates Forum shall not remove the Licensee’s right to participate=
in
that forum.
11. =
REPRESENTATIONS
AND WARRANTIES
11.1 To the extent permitted by law, the
Licensor excludes all representations, warranties and conditions that would
otherwise be implied by law in this Licence Agreement (including, without
limitation, all implied warranties of merchantability or fitness for a
particular purpose).
11.2 Without limiting clause 11.1=
, the
Licensor does not represent or warrant that the International Release or any
part of it will satisfy any of the Licensee’s requirements, operate in
combinations selected by the Licensee or be free from defects or errors.
12. =
LIMITATION
OF LIABILITY
12.1 The Licensor shall not be liable to=
the
Licensee or to any other person, whether in contract, tort (including negli=
gence),
misrepresentation, breach of statutory duty or otherwise, for any of the
following arising under or in connection with this Licence Agreement
(including, without limitation, in respect of the Licensee’s use of or
inability to use the International Release or any part of it):
12.1.1 indirect or consequential loss;
12.1.2 special or punitive damages;
12.1.3 loss of profits, loss of savings an=
d loss
of revenue;
12.1.4 loss of business, loss of reputatio=
n and
loss of goodwill; and
12.1.5 loss of data.
12.2 Neither the Licensor nor any Member=
shall
be liable to the Licensee or any other person for any failure by the Licens=
or
or the Member (as the case may be) to maintain or distribute any Extension =
(or
part thereof) or Derivative transferred to the Licensor or the Member (as t=
he
case may be) in accordance with clauses 3.4 or 3.5.
12.3 The liability of the Licensor arisi=
ng in
any year under or in connection with this Licence Agreement, whether in
contract, tort (including negligence), misrepresentation, breach of statuto=
ry
duty or otherwise, shall not in any event exceed the Licence Fees paid by t=
he
Licensee in respect of that year.
12.4 Nothing in this Licence Agreement
excludes or limits the liability of either party for:
12.4.1 fraud (including fraudulent
misrepresentation);
12.4.2 death or personal injury caused by =
the
negligence of that party;
12.4.3 any breach of its obligations impli=
ed by
section 12 of the Sale of Goods Act 1979; or
12.4.4 any other liability that by law can=
not
validly be excluded or limited (but only to the extent that the liability
cannot validly be excluded or limited).
13. =
ASSIGNMENT
13.1 The Licensee may not assign, novate=
or
otherwise transfer any of its rights or obligations under this Licence
Agreement to any person without the prior written consent of the Licensor n=
ot
to be unreasonably withheld.
13.2 The Licensor may transfer all of its
rights and obligations under this Licence Agreement to any person to whom t=
he
Licensor transfers the Intellectual Property Rights in respect of which the
licences under this Licence Agreement are granted.
14. =
GENERAL
PROVISIONS
14.1 This Licence Agreement contains the
entire agreement between the parties relating to the subject matter of this
Licence Agreement, supersedes all previous agreements between the Parties
relating to that subject matter and sets out the entirety of the
Licensee’s rights in respect of the International Release.
14.2 Each party acknowledges that, in en=
tering
into this Licence Agreement, it has not relied on any representation, warra=
nty,
collateral contract or other assurance made by on behalf of the other party
before the date of this Licence Agreement.
14.3 Except as provided in clause 6.3=
,
this Licence Agreement may not be varied except in writing signed by both
parties and expressed to vary this Licence Agreement.
14.4 Nothing in this Licence Agreement s=
hall
give either party the ability to act or incur obligations or liability on
behalf of the other party or constitutes a joint venture, agency, partnersh=
ip
or employment relationship between the parties.
14.5 If any term of this Licence Agreeme=
nt is
or becomes illegal, invalid or unenforceable in any jurisdiction, that shall
not affect the legality, validity or enforceability in that jurisdiction of=
any
other term of this Licence Agreement, or the legality, validity or
enforceability in any other jurisdiction of that or any other term of this
Licence Agreement.